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Chapter One: Introduction 
 
Ischemia reperfusion injury induced acute kidney injury 
Acute kidney injury (AKI) has been described as a rapid loss of renal function by 
sudden and sustained decrease of glomerular filtration rate (GFR) with retention of 
nitrogenous waste products (Bauerle et al. 2011, Mehta et al. 2007, Thadhani et al. 
1996). AKI occurs in approximately 20% of hospital admissions and is increasingly 
common in critically ill patients (Liangos et al. 2006, Uchino et al. 2005, Uchino et al. 
2006). AKI is responsible for approximately 2 million deaths annually worldwide and 
costs approximately $10 billion annually in the United States (Ali et al. 2007, Liangos et 
al. 2006, Murugan & Kellum 2011, Uchino et al. 2005, Uchino et al. 2006). The classic 
teaching regarding patients who survive an episode of AKI, in particular acute tubular 
necrosis, was that those patients achieved full or nearly full recovery (FINKENSTAEDT 
& Merrill 1956, Kjellstrand et al. 1981, LOWE 1952). AKI can cause end-stage renal 
disease directly, and increase the risk of developing incident chronic kidney disease 
(CKD) and worsening of underlying CKD. In addition, severity, duration, and frequency 
of AKI appear to be important predictors of poor patient outcomes (Amdur et al. 2009, 
Chawla et al. 2011, Chawla & Kimmel 2012, Garg et al. 2003, Ishani et al. 2009, Lo et 
al. 2009, Wald et al. 2009). Patients with AKI are also more likely to experience 
systemic morbidity, longer hospital length of stay, functional impairment, eventual 
development of end stage kidney failure, and increased long-term mortality (Bihorac et 
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al. 2009, Coca et al. 2009, Hsu et al. 2009, Johansen et al. 2010, Levy et al. 1996, Liss 
et al. 2006, Parikh et al. 2008, Wald et al. 2009). Even patients with transient AKI 
experience worse long-term outcomes (Goldenberg et al. 2009, Hobson et al. 2009, 
Welten et al. 2007). Even though, biomarkers of tubule injury, such as kidney injury 
molecule–1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL), both being 
present in the urine of animals and patients with AKI, have been found to be useful 
noninvasive biomarkers of kidney injury (Bonventre et al. 2010, Han et al. 2002, Mishra 
et al. 2005, Vaidya et al. 2008a, Vaidya et al. 2008b, Vaidya et al. 2010); however, at 
present, no specific therapy to prevent or treat AKI or its complications exists (Chertow 
et al. 2005, Faubel et al. 2012, Okusa et al. 2012).  
Ischemia reperfusion injury (IRI) induced AKI is typically divided into initiation, 
extension, maintenance and recovery phases. Severe injuries of thick ascending limb 
(TAL) in the outer medulla and proximal tubular in renal cortex are uniform features in 
various forms of AKI (Heyman et al. 1988, Lieberthal & Nigam 1998, Oken 1975, 
Regner et al. 2009). Tubular obstruction with epithelial debris and backleak are 
proposed to contribute to the initial phase for the reduction of GFR (Devarajan 2006, 
Eltzschig & Eckle 2011, Glodowski & Wagener 2015). 
Ischemia and reperfusion are unavoidable steps during kidney procurement and 
transplantation. Transplanted organs experience several episodes of IRI, which can be 
caused by both warm and cold ischemia. Warm ischemia occurs after cardiac death in 
donors, or during the harvesting operation on living donors, and during anastomosis of 
the graft. Cold ischemia occurs during allograft kidney storage in organ preservation 
solutions (Homer-Vanniasinkam et al. 1997, Ploeg et al. 1988, Southard et al. 1985), 
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which was invented in 1960’s. The invention of preservation solutions is the most 
seminal step to avoid IRI, allowing for safe renal preservation exceeding 24 hours 
(Collins et al. 1969, Wahlberg et al. 1987) : it remains the mainstay of preservation for 
kidney allografts worldwide(O'Callaghan et al. 2012, Opelz & Dohler 2007). 
Post-transplant renal injury has been studied extensively (Gulec et al. 2006, Land 
1999, Massberg & Messmer 1998, Racusen et al. 1999, Sis et al. 2010). Prolonged 
ischemia increases the occurrence of delayed graft function and worsens long-term 
graft survival (Boom et al. 2000). IRI is one of the most important nonspecific factor 
affecting both delayed and late allograft dysfunction (Halloran et al. 1988, Jassem & 
Heaton 2004, Womer et al. 2000). RIFLE (risk, injury, failure, loss, end stage renal 
disease) and acute kidney injury network criteria are the generally accepted definitions 
of an AKI episode in native kidneys (Bellomo et al. 2004, Mehta et al. 2007), which are 
largely based on the degrees of plasma creatinine elevation from baseline. There are no 
official recommendations regarding specific diagnostic criteria for AKI in the kidney 
transplant, primarily due to the difficulties in determination of the baseline creatinine 
levels in graft recipients (Cavaille-Coll et al. 2013, Cooper & Wiseman 2013, 
Kosieradzki & Rowinski 2008). The limited published studies of transplant AKI 
epidemiology and outcomes have adopted the criteria for native kidneys (Mehrotra et al. 
2012, Nakamura et al. 2012). IRI-induced AKI has been found crucial for transplanted 
kidney survival. Recently AKI and graft survival of renal transplant recipients has been 
analyzed in a large retrospective cohort study included 27,232 patients. Patients who 
developed AKI had an increased risk of graft loss and an increased risk of mortality 
(Mehrotra et al. 2012). IRI has been proposed to activate the immune system and 
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facilitate T cell interactions that possible leads to rejection (Daemen et al. 2002, 
Pratschke et al. 2001), even though IRI is independent of the immunologic background 
(Dragun et al. 2000).  
If blood is returned to ischemic tissue before a critical time, organ function is 
quickly restored (Dawidson et al. 1991). However, if ischemia lasts a longer time, 
irreversible damage and even graft failure would occur. At present it is not possible to 
prevent AKI during transplantation. The worldwide organ shortage has stimulated the 
interest in research to minimize IRI. Post-transplant renal failure has been studied 
extensively (Cavaille-Coll et al. 2013). Numerous clinical trials and analyses have been 
conducted, various drug products have been tested in clinical trials in the peri-transplant 
period.  A few have demonstrated early improvements in graft function (Goggins et al. 
2003, Rabl et al. 1993, Shilliday & Sherif 2004), but none have shown an improvement 
in late graft function (Finn 1990, Fontana et al. 2005, Goggins et al. 2003, Hladunewich 
et al. 2003, Lachance & Barry 1985, Martinez et al. 2010, Michael et al. 1989, Noel et 
al. 1997, Rabl et al. 1993, Salmela et al. 1999, Shilliday & Sherif 2004).  
 
Renal hemodynamics in acute kidney injury 
In both humans and experimental animals, an intense and persistent renal 
vasoconstriction that reduces overall kidney blood flow and GFR has long been 
considered a hallmark of AKI (Lameire et al. 2005, Mason et al. 1977). It has been 
reported that vascular response increased to vasoconstrictive agents, and decreased to 
vasodilatory agents in arterioles taken from post-ischemic kidneys when compared with 
those taken from normal kidneys (Conger & Weil 1995, Oken 1975, Oken 1984). Even 
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though direct data are still missing, tubuloglomerular feedback (TGF) responsiveness 
has been postulated to contribute to the enhanced preglomerular vascular resistance 
and reduction in GFR in AKI (Thurau & Boylan 1976). The commonly used AKI animal 
models, which involve clamping renal arteries or pedicles, closely mimics the 
mechanisms and futures of kidney transplantation (Cavaille-Coll et al. 2013).  
Decreased GFR in AKI is generally believed to be the consequence of reduced  
renal blood flow (RBF), but in AKI patients, RBF was found to have only a limited or no 
detectable association with GFR, in a literature review of articles published from 1944-
2008 (Prowle et al. 2009, Prowle et al. 2010). The clinical trials utilizing vasodilators in 
the AKI have largely failed, which included dopamine (Denton et al. 1996), fenoldopam 
mesylate (Tumlin et al. 2005), atrial natriuretic peptide (Allgren et al. 1997), brain-type 
natriuretic peptide (Mentzer, Jr. et al. 2007) and insulin growth factor-1 (Hirschberg et 
al. 1999). Therefore, the pathophysiological mechanisms for IRI are complicated and 
regulated by multiple factors that have not been fully clarified.  
Severe injuries of the proximal tubular in renal cortex and TAL in the outer 
medulla is a uniform feature in various forms of AKI while the glomeruli are 
morphologically normal (Heyman et al. 1988, Lieberthal & Nigam 1998, Oken 1975, 
Regner et al. 2009). Tubular injury can also lead to a decrease in GFR by tubular 
obstruction with epithelial debris and backleak. However, normal pressures have been 
observed in several tubules, making it unlikely for tubular obstruction to be the singularly 
important mediator of reduction in GFR after ischemic injury (Conger et al. 1984). 
Arendshorst et al. (Arendshorst et al. 1975) studied severe AKI after 1 h of unilateral 
renal ischemia. They found that in the early stages (1-3 h) after ischemia, the pressures 
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in the proximal and distal tubules were elevated, and there was histological evidence of 
tubular obstruction. Tubular obstruction appeared to be the predominant factor in the 
decline in filtration rate at this stage. However, at a later time-point (22-26 h), tubular 
pressures were normal, but preglomerular vasoconstriction was marked and this was 
thought to contribute to the persistent decline in filtration rate. In addition, tubular 
obstruction does not appear to be a significant pathogenic mechanism in AKI in 
humans, in which only about 10% decrease in GFR could be explained by tubular 
backleak (Blantz & Singh 2011, Braam et al. 1993, Myers et al. 1979, Schrier et al. 
2004). A single nephron model of nephrotoxic tubular injury was established by 
microperfusion of uranyl nitrate into the early proximal tubule (Peterson et al. 1989). 
Within minutes of intratubular administration of uranyl nitrate, a 16-30% reduction in 
single nephron glomerular filtration rate (SNGFR) was observed. The local mechanism 
such as TGF could be invoked to explain the immediate decline in SNGFR. Similar 
findings have been observed in the uranyl nitrate model of AKI by another group 
(Flamenbaum et al. 1974).  
Renal microvasculature plays a major role in maintaining hemodynamics and 
tubular functions. Loss of peritubular capillaries has been found to correlate with CKD in 
both animal models (Basile 2007, Kang et al. 2001, Kang et al. 2002, Ohashi et al. 
2002, Yuan et al. 2003) and patients (Bohle et al. 1996, Kaukinen et al. 2009, 
Lindenmeyer et al. 2007). In transplanted kidneys, fewer peritubular capillaries are 
associated with the development of interstitial fibrosis and graft dysfunction (Cooper & 
Wiseman 2013, Ishii et al. 2005, Snoeijs et al. 2011), which is a major cause of renal 
graft loss (Nankivell et al. 2003, Perico et al. 2004). A recent clinical study found that 
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peritubular capillary loss occurs during the first 3 months after renal transplantation, 
which associates with increased interstitial fibrosis and tubular atrophy and predicts 
reduced graft function (Steegh et al. 2011). The densities of peritubular capillaries have 
also been found to decrease with aging in animals (Kang et al. 2002). Kidneys 
transplanted from older donors have shorter half-life graft survival times (de Fijter et al. 
2001, Snoeijs et al. 2008), suggesting that fewer peritubular capillaries or impaired 
angiogenesis may contribute to the decreased graft function. Microvasculature injuries 
enhance vasoactive factors such as Ang II, adenosine and renal sympathetic nerves 
and inhibit vaso-dilatation factors such as nitric oxide (NO), prostaglandin and 
dopamine, thereby promoting vascular constriction and enhancing local ischemia 
(Johnson & Schreiner 1997, Sanchez-Lozada et al. 2003). Therefore, peritubular 
capillary injury can potentially cause local hypoxia, chronic ischemia and interstitial 
inflammation, which promotes further interstitial and capillary injury, leading to interstitial 
fibrosis (Aird 2003, Eddy 2000, Granger & Kubes 1994, Imhof & Dunon 1995, Kang et 
al. 2002, Keller et al. 2003, Nangaku 2004, Robson et al. 1995, Sanchez-Lozada et al. 
2003). 
Elevations of glomerular capillary pressure have been considered a major risk 
factor and play an essential role in development of CKD and diabetic nephropathy 
(Anderson & Brenner 1986, Anderson & Vora 1995, Bohle et al. 1996, Dunn et al. 1986, 
Johnson & Schreiner 1997, Sanchez-Lozada et al. 2003, Zatz et al. 1986). Glomerular 
capillary pressure has also been measured in chronic rejection animal models (Junaid 
et al. 1994, Kingma et al. 1993, Ziai et al. 2000).  In transplanted kidneys with chronic 
rejection, the capillary pressure has been found to be significant higher compared with 
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animals without rejection. Other studies evaluated the nephron mass and graft function. 
They found that nephron mass is a major determinant for intraglomerular capillary 
pressure and graft function of the transplanted kidneys (Mackenzie et al. 1994, 
Mackenzie et al. 1995). Even though glomerular capillary pressure cannot be measured 
directly in human kidneys, the results from several clinical observations demonstrate a 
possible connection between chronic rejection and glomerular hypertension, by 
evaluation of potential risk factors that could potentially raise glomerular pressure, such 
as nephron mass, body weight, GFR and protein diet (Barrientos et al. 1994, Brenner et 
al. 1992, Feldman et al. 1996, Pirsch et al. 1995, Salahudeen 2003, Terasaki et al. 
1994). These data from both animal experiments and clinical observations support the 
hypothesis that glomerular capillary pressure is a risk factor for chronic rejection and 
graft function. 
Few studies have evaluated the relationship between pressure and tubular cell 
injury. Increasing intra-tubular pressure and tubular stretch upregulates transforming 
growth factor β-1 (TGFβ-1), which is considered to contribute to tubulointerstitial 
inflammation and fibrosis in the unilateral ureteral obstruction model (Quinlan et al. 
2008, Sato et al. 2003). Cyclical stretch on renal epithelial cells has been reported to 
induce apoptosis by activating JNK/SAPK and p38 SAPK-2 pathways (Nguyen et al. 
2006). In addition, renal vein occlusion results in more severe tubular injury and higher 
levels of plasma creatinine than renal arterial occlusion in C57BL/6J mice (Li et al. 
2012). In patients with chronic heart failure, venous congestion was found to be an 
important determinant of kidney function as measured by GFR (Damman et al. 2007). 
9 
 
These studies also suggest that higher tubular pressure might contribute to kidney 
injury. However, the role of intra-tubular pressure in the development of AKI is unknown. 
 
Warm and cold renal ischemia  
IRI-induced AKI, which has been extensively studied, closely mimics IRI in 
kidney transplantation in humans (Cavaille-Coll et al. 2013), even though no single 
animal model duplicates human disease. Warm ischemia models achieved graded 
responses by varying experimental conditions such as temperature, duration of 
clamping and site of clamping, such as bilateral, unilateral, artery, vein or pedicle 
clamping (Burne-Taney et al. 2003, Chen et al. 2007, Jang & Rabb 2015, Khajuria et al. 
2014, Kinsey et al. 2008, Malek & Nematbakhsh 2015).  
The invention of organ preservation solutions has enormously protected graft 
damage induced by cold ischemia and made it possible to safely preserve renal graft for 
over 24 hours (Collins et al. 1969, Homer-Vanniasinkam et al. 1997, Ploeg et al. 1988, 
Southard et al. 1985, Wahlberg et al. 1987). However, transplanted kidneys usually 
undergo both cold and warm ischemia. Even though cold ischemia has been studied 
extensively for a long time, all of the studies that specifically focused on cold ischemia 
have been carried out in vitro and ex vivo models. There is no available in vivo model to 
examine IRI induced only by cold ischemia (Ishitsuka et al. 2013, O'Callaghan et al. 
2012, Salahudeen 2004, Sorensen et al. 2011, Turkmen et al. 2011). 
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Renal autoregulation and tubuloglomerular feedback 
Renal autoregulation is an intra-renal mechanism that maintains RBF and GFR 
relatively constant independent of systemic blood pressure over a range about 80-180 
mmHg. Renal autoregulation is a vital mechanism that maintains normal kidney 
clearance function and protects the kidney from elevation in arterial pressure, which 
causes kidney injury. The two highly coordinated mechanisms that largely mediate the 
renal autoregulation are myogenic and tubuloglomerular feedback (TGF) responses, 
which regulate preglomerular vasotone primarily of the afferent arteriole (Af-Art) (Burke 
et al. 2014, Carlstrom et al. 2015, Hall 2015). The myogenic response of the Af-Art 
responds rapidly, usually occurring within 1-2 secs following changes in arterial 
pressure.  In contrast, TGF acts more slowly: usually the response delay is 10-30 secs 
following changes in arterial pressure (Abu-Amarah et al. 2005, Chon et al. 1993, 
Cupples et al. 1996, Daniels & Arendshorst 1990, Just 2007, Pires et al. 2002). 
The myogenic response is an intrinsic property of the vascular smooth muscle 
cells in small arteries that constrict in response to elevations in transmural pressure. 
The myogenic response varies greatly among different vascular beds. The renal 
vasculature has the fastest and most complete response compare to other organs 
(Carlstrom et al. 2015). Af-Arts are believed to be the major resistant vessels in kidneys 
and therefore expected to largely mediate the myogenic response in the kidney 
(Carmines 2010).  
The existence of the TGF system was predicted in the 1930s by Goormaghtigh 
(Goormaghtigh N. 1937) and Zimmerman (Zimmerman 1933). Major advances in our 
understanding of the TGF system have been made using in vivo renal micropuncture 
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and in vitro microperfusion of isolated juxtaglomerular apparatus (JGA) (Ito & Carretero 
1991, Liu et al. 2002, Moore et al. 1979, Navar 1978, Navar et al. 1996, Ploth et al. 
1979, Schnermann et al. 1976a, Schnermann & Briggs 1999, Thurau & Schnermann 
1965, Wilcox & Welch 1996). TGF response operates within each nephron principally 
through the JGA and renders the single nephron GFR inversely dependent on the 
tubular flow rate past the macula densa. The macula densa is a group of specialized 
epithelial cells located at the distal segment of the TAL; it serves as a sensor of luminal 
NaCl concentration. Increases of NaCl delivery to the macula densa promotes release 
of adenosine and/or ATP, which constricts Af-Art and decreases SNGFR: a process 
called the TGF response.  It establishes a negative feedback by which a change in 
tubular flow to the macula densa induces a reciprocal change in SNGFR, thus 
preventing acute fluctuations of flow and NaCl delivery in the distal nephron (Briggs & 
Schnermann 1986, Ollerstam et al. 1997, Ren et al. 2000b, Schnermann & Briggs 1992, 
Welch et al. 2000, Welch & Wilcox 1990). TGF is regulated by various factors including 
Ang II (Ren et al. 2002c, Welch & Wilcox 1990), adenosine (Ren et al. 2002a, Sun et al. 
2001), arachidonic acid metabolites (Kurtz et al. 1986, Ren et al. 2000a), ATP (Inscho 
et al. 1992, Ren et al. 2004), atrial natriuretic factor (Huang & Cogan 1987), superoxide 
(Liu et al. 2004b, Ren et al. 2002b, Welch et al. 2000) and NO (Ito et al. 1993, Liu et al. 
2004b, Schnermann 1998, Welch & Wilcox 1997). NO is synthesized by 3 isoforms of 
NOS: Neuronal NOS (nNOS or NOS1), inducible NOS (iNOS or NOS2), and endothelial 
NOS (eNOS or NOS3), all of which are expressed in the kidney. While NOS2 is 
calcium-insensitive isoform, NOS1 and NOS3 are constitutive enzymes and sensitive to 
calcium (Lamattina et al. 2003). NOS1 is a predominant isoform expressed in macula 
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densa cells (Mundel et al. 1992, Wilcox et al. 1992). NO generated by the macula densa 
inhibits TGF response (Ito et al. 1993, Liu et al. 2004b, Schnermann 1998, Welch & 
Wilcox 1997). We have recently published several studies that significantly advance the 
understanding of these mechanisms. We showed that macula densa cells in the kidney 
express α, β, and γ splice variants of neuronal nitric oxide synthase (NOS1) (Lu et al. 
2010). NOS1β is the primary splice variant and contributes to most of the NO 
generation by the macula densa in rodents. Mice with NOS1 deleted specifically from 
the macula densa develop salt-sensitive hypertension, associated with enhanced TGF 
responsiveness and attenuation of increases of GFR. 
Renal autoregulation can be analyzed by different in vivo and in vitro methods: 1) 
RBF measurement and analysis: RBF of whole kidney or in different regions of the 
kidney is measured while renal arterial pressure is adjusted to evaluate autoregulatory 
response. Renal arterial pressure is adjusted to step reduction by constriction of the 
suprarenal aorta or increase by collusion of the mesenteric and/or celiac arteries 
(Arendshorst 1979, Mattson et al. 1993, Roman et al. 1988). Renal autoregulation can 
also be studied by dynamic analysis of RBF by measuring time and frequency domains, 
which can separate myogenic and TGF response components (Cupples & Loutzenhiser 
1998, Daniels et al. 1990, Holstein-Rathlou & Marsh 1994, Holstein-Rathlou et al. 1991, 
Just 2007); 2) TGF and myogenic response measurement: TGF response can be 
measured in isolated perfused JGAs in vitro (Ito et al. 1989, Kirk et al. 1985) and with 
micropuncture in vivo (Bell et al. 1984, Schnermann et al. 1976b). Myogenic response 
can be measure in isolated perfused Af-Arts (Edwards 1983, Ito et al. 1989), in the 
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juxtamedullary glomerular preparations (Casellas & Navar 1984, Moore & Casellas 
1990) and in the hydronephrotic kidney (Hayashi et al. 1989).  
Urine pH in healthy individuals fluctuates over the entire physiological range of 
values from 4.5 -8.5 (Bilobrov et al. 1990). Urine pH in each individual demonstrates 
marked variations throughout the day, but with patterns. A nocturnal peak in urine pH 
was usually seen around 22:00. Throughout the night, urine pH decreased to a nadir 
around 06:00 before rising again in the morning (Ayres et al. 1977, Barnett & Blume 
1938, Cameron et al. 2012, ELLIOT et al. 1959, Jones 1843, Kanabrocki et al. 1988, 
MILLS & STANBURY 1951, STANBURY & THOMSON 1951). Diet can markedly 
affect acid-base status. Dietary acid load has been found to be associated with serum 
bicarbonate levels and urine pH (Gunn et al. 2013, Ikizler et al. 2015, Remer & Manz 
1995). The European Prospective Investigation into Cancer and Nutrition study 
analyzed 22,034 men and women and compared casual urine samples with dietary acid 
load. They found that dietary acid-base load was significantly related to urine pH. 
Casual urine pH provides a simple tangible measure of dietary acid load (Welch et al. 
2008). A recent study reported that urine pH is sensitive to reflect dietary acid-base load 
and reach a steady state in about 3 days (Kanbara et al. 2012).  
Current guidelines for CKD patients recommend alkali treatment with sodium 
citrate or sodium bicarbonate for those with serum total carbon dioxide (CO2) less than 
22 mM. Indeed, the correlation between low serum bicarbonate level and progressive 
decline in estimated GFR (eGFR) has been studied extensively in patients with CKD. 
Alkali therapy reduces kidney injury and slows nephropathy progression in patients with 
CKD (de Brito-Ashurst et al. 2009, Dobre et al. 2015, Eustace et al. 2004, Goraya et al. 
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2012, Kovesdy et al. 2009, Mahajan et al. 2010, Navaneethan et al. 2011, Phisitkul et 
al. 2010, Raphael et al. 2011, Shah et al. 2009, Susantitaphong et al. 2012), but the 
mechanism is not clear. 
Diet can markedly affect acid-base status and it significantly influences CKD and 
its progression. In the National Health and Nutrition Examination Survey, 11,957 adults 
were analyzed  and found that high serum anion gap values and decreased serum total 
CO2 concentration were associated with increased mortality in the general population 
and with a decline in eGFR in patients with CKD (Abramowitz et al. 2012). In a separate 
study, the correlation between dietary acid load and eGFR were assessed in 12,293 US 
adults. High dietary acid load was found to be associated with albuminuria and low 
eGFR (Banerjee et al. 2014). A cross-sectional study of the African American Study of 
Kidney Disease and Hypertension (AASK) cohort indicate that a higher acid load and 
lower total serum CO2 concentration (reflects serum bicarbonate concentration) 
correlate with more severe CKD and readily decline of eGFR (Scialla et al. 2011). 
Oral bicarbonate supplementation slows CKD progression in humans (de Brito-
Ashurst et al. 2009). Recent two intervention studies, one in patients with early CKD 
without metabolic acidosis (Goraya et al. 2012), and the other in patients with advanced 
CKD and metabolic acidosis (Goraya et al. 2013), suggest that a diet rich in fruits and 
vegetables can improve renal function and slow the progression of CKD. In patients at 
risk of CKD, alkali-generating diets that are rich in fruits and vegetables reduce the risk 
of developing CKD (Chang et al. 2013, Dunkler et al. 2013, Lin et al. 2011, Nettleton et 
al. 2008, Scialla et al. 2011). Oral bicarbonate supplementation has been found to delay 
the decline of GFR in CKD patients (Dobre et al. 2015, Eustace et al. 2004, Kovesdy et 
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al. 2009, Navaneethan et al. 2011, Raphael et al. 2011, Shah et al. 2009, 
Susantitaphong et al. 2012), but the mechanism is not clear. Recently, the relationship 
between serum bicarbonate and GFR has been analyzed in people with normal renal 
functions. Lower serum bicarbonate concentrations are found to be associated 
independently with rapid decline of eGFR in a study of 5422 adults; in a Multi-Ethnic 
Study of Atherosclerosis of 5810 participants (Driver et al. 2014), and in a Health, 
Aging, and Body Composition study (Goldenstein et al. 2014). The baseline eGFR of 
most or all of the participants in these studies is above 60 mL/min/1.73 m2. 
Dietary acid load has also been found an important determinant of kidney injury 
in rat models of CKD with and without metabolic acidosis (Khanna et al. 2004, Mahajan 
et al. 2010, Nath et al. 1985, Phisitkul et al. 2010, Wesson et al. 2006, Wesson & 
Simoni 2010).  
In summary, most of the available data suggest that alkali intervention by diets 
rich in fruits and vegetables or oral bicarbonate supplementation improve renal function 
and slow decline in eGFR in normal population and patients with CKD with and without 
metabolic acidosis. Urine pH reflects dietary acid-base load and plasma bicarbonate 
levels.  
 
Renal infarction 
Renal infarction, characterized with an interruption of blood supply to a portion of 
or the whole kidney, could result in irreversible kidney damage and subsequent necrosis 
of renal parenchyma along with a decline in kidney function (Bourgault et al. 2013, 
Eltawansy et al. 2014). The incidence of renal infarction was reported at approximate 
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0.003 to 0.007% in previous clinical studies (Domanovits et al. 1999, Huang et al. 2007, 
Korzets et al. 2002, Paris et al. 2006). However, due to a lack of specific clinical 
manifestation, renal infarction is frequently underdiagnosed and its incidence is largely 
underestimated. According to the results of a retrospective postmortem study, 205 renal 
infarction cases were diagnosed in a total of 14411 autopsies, indicating an actual 
incidence could be around 1.4%. 
 
Renal infarction and hypertension 
The epidemiology of renal infarction is complex and has not been completely 
understood. Various risk factors, including arteriosclerosis, atrial fibrillation (Antopolsky 
et al. 2012a, Frost et al. 2001, Saeed 2012), hypercoagulation (Antopolsky et al. 2012a, 
Saeed 2012) and endocarditis (Antopolsky et al. 2012a, Lumerman et al. 1999, Wong et 
al. 1984) are involved with renal infarction. Renal thromboembolism originated from the 
heart or aorta is recognized as the primary cause of renal infarction (Eltawansy et al. 
2014, Korzets et al. 2002, Saeed 2012).  Despite of a few case reports with normal 
blood pressure (Alamir et al. 1997, Javaid et al. 2009), hypertension is commonly 
observed in renal infarction. Based on the outcomes of a retrospective cohort study, 
hypertension was identified in 48% of the renal infarction patients (Bourgault et al. 
2013). Another retrospective clinical study also indicated that renal infarction resulted in 
acute or aggravated hypertension in previous normotensive or hypertensive patients. 
The renal infarction-induced hypertension was usually ameliorated following surgery or 
renal artery angioplasty (Paris et al. 2006). However, the pathophysiological changes in 
17 
 
renal infarction and the mechanisms of renal infarction induced hypertension have not 
been fully understood. In addition, mouse models of partial renal infarction are lacking.  
 
Renal infarction and chronic kidney disease 
CKD is characterized by a progressive loss in kidney function and could 
eventually develop into end stage renal disease (ESRD). CKD is a major health issue in 
the United States with increasing morbidity and significant costs. Based on the National 
Kidney Foundation Kidney Disease Outcome Quality Initiative clinical practice 
guidelines for CKD, the prevalence of CKD in the U.S. is approximate 13.1% and the 
estimated population of ESRD is over 0.7 million by 2015 (Coresh et al. 2007, 
Gilbertson et al. 2005). The risk factors for CKD are diverse and the epidemiology is 
usually multiplicate. Currently, diabetes mellitus and high blood pressure have been 
recognized as the two primary causes of CKD (Islam et al. 2009, Levey et al. 2010). 
Despite of extensive investigation, the pathophysiological mechanisms of CKD have not 
been completed elucidated. A better understanding of CKD might provide potential 
therapeutic targets and advance the clinical strategies to prevent or attenuate its 
progression. 
Various animal models have been developed to study CKD. Five-sixths renal 
mass reduction, produced by uninephrectomy plus 2/3 renal parenchyma reduction on 
the contralateral kidney, is a broadly used model in rat to mimics the CKD secondary to 
reduced nephron number, in which kidney function gradually decrease accompanied 
with progressive proteinuria and glomerulosclerosis (Purkerson et al. 1976, Shimamura 
& Morrison 1975, Yang et al. 2010). Moreover, compared with renal mass reduction 
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through surgical excision of both upper and lower poles, the approach via ligation in two 
of the three renal artery branches resulted in higher blood pressure and more severe 
renal injury. Unlikely to the model of rat, the development of progressive CKD following 
5/6 nephrectomy in mice is highly strain-dependent. C57BL/6 mouse, the most 
commonly used laboratory rodent, is relatively blood pressure and renal injury resistant 
to five-sixths nephrectomy by uninephrectomy combined with the resection of 2/3 
contralateral kidney. Addition of angiotensin II administration is the only strategy so far 
to overcome the resistance of CKD development in 5/6 nephrectomy model of C57BL/6 
mouse (Leelahavanichkul et al. 2010). 
Five-sixths nephrectomy, produced by uninephrectomy and surgical removal of 
2/3 contralateral kidney, is a well-established and widely used CKD model in various 
kinds of laboratory animals, such as dog (Bourgoignie et al. 1987, COBURN et al. 1965, 
Robertson et al. 1986), rabbit (Eddy et al. 1986, Kilicarslan et al. 2003) and rat (Griffin et 
al. 1994, Laouari et al. 1997, Shimamura & Morrison 1975) with the progressive 
reduction in kidney function and the development of renal injury, which mimics the 
feature of CKD in human. However, it has been recognized that the susceptibility to 
develop CKD following 5/6 nephrectomy is strain or genetic background dependent in 
mouse. A recent study by Leelahavanichkul et al. showed that progressive CKD, as 
indicated by the gradual decrease in GFR, the reciprocal changes in blood urea 
nitrogen and serum creatinine, severe albuminuria and mesangial expansion in 
glomeruli, was developed by 4 weeks in CD-1 mice and by 12 weeks in 129S3 mice 
after 5/6 nephrectomy in which the upper and lower poles of the left kidney were 
resected and the whole right kidney was removed. In addition, conscious blood 
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pressure measured by radiotelemetry was significantly elevated in both CD-1 mice and 
129S3 mice following 5/6 nephrectomy. In contrast, C57BL/6 mouse model with 5/6 
nephrectomy exhibited normal blood pressure and was relatively resistant to renal injury 
in the remnant kidney (Leelahavanichkul et al. 2010). C57BL/6 mouse is the most 
popular laboratory rodent with its advantage of stability in physiological characteristics 
and heredity. Furthermore, C57BL/6 is first strain of mouse that had its genome 
completely sequenced and the most broadly utilized strain as background in the 
generation of genetically modified mouse. Thus, to develop animal model in C57BL/6 
mouse is of greater significance. Besides nephrectomy, other approaches, such as 
ligation of kidney poles (Perez-Ruiz et al. 2006) and ligation of renal artery branches 
(Griffin et al. 1994, Yang et al. 2010), have also been reported to achieve a subtotal 
renal mass reduction in rats. Moreover, compared with the approach surgical excision, 
5/6 renal mass reduction, which was produced by uninephrectomy and 2/3 renal 
parenchyma infarction via ligation in two of the three renal artery branches on 
contralateral kidney, induced higher blood pressure and more severe renal injury in 
Sprague-Dawley rats (Griffin et al. 1994). 
 
Hypothesis 
 
General Hypothesis 
Renal ischemia is related with different kinds of kidney diseases. Temporary 
ischemia in kidney could lead to renal ischemia reperfusion induced AKI. The 
pathophysiological mechanisms of AKI are complicated and are not well elucidated. We 
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would like to determine the role of various factors including intratubal pressure, renal 
temperature and renal pH in ischemia reperfusion induced AKI. Permanent ischemia in 
kidney could result in renal infarction. We sought to examine whether permanent partial 
renal ischemia promotes the development of CKD in the remnant kidney tissue and 
investigate the potential mechanisms (Figure 1).  
Hypothesis I: Increased intratubular pressure of the proximal tubule during the 
ischemic phase exacerbates renal ischemia reperfusion injury and promotes the 
development of AKI. 
Renal ischemia is related with different kinds of kidney diseases. Temporary ischemia in 
kidney could lead to renal ischemia reperfusion induced AKI. We would like to 
determine the role of various factors including intratubal pressure, renal temperature 
and renal pH in ischemia reperfusion induced AKI. Permanent ischemia in kidney could 
result in renal infarction. We sought to examine whether permanent partial renal 
ischemia promotes the development of CKD in the remnant kidney tissue and 
investigate the potential mechanisms. 
 
Figure 1. Ischemia renal disease. 
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Hypothesis II: Renal temperature during the ischemic phase affects the 
pathophysiological process of IRI induced AKI  
Hypothesis III: 1) Renal pH modulates TGF response by regulating NOS1β in the 
macula densa; 2) Renal IRI downregulates NOS1β in the macula densa and enhances 
TGF response, which promotes the development of AKI; 3) Bicarbonate treatment 
protected against IRI-induced AKI by upregulating NOS1β in the macula densa. 
Hypothesis IV: Partial renal infarction by ligating either the upper or lower branch 
of the renal artery in the left kidney while the right kidney remained intact is able to 
induce hypertension in C57BL/6 mouse.  
Hypothesis V: Five sixth renal mass reduction by uninephrectomy and upper 
renal artery branch ligation on the contralateral kidney increases blood pressure and 
promotes CKD progression in C57BL/6 mouse. 
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Chapter Two: Ischemia Reperfusion Injury Induced Acute Kidney Injury 
 
Project I: the role of intratubular pressure during the ischemic phase in acute 
kidney injury 
 
Abstract 
Acute kidney injury (AKI) induced by clamping of renal vein or pedicle is more 
severe than clamping of artery, but the mechanism has not been clarified. In present 
study, we tested our hypothesis that increased proximal tubular pressure (Pt) during the 
ischemic phase exacerbates kidney injury and promotes the development of AKI. We 
induced AKI by bilateral clamping of renal arteries, pedicles or veins for 18 min at 37° 
C, respectively. Pt during the ischemic phase was measured with micropuncture. We 
found that higher Pt was associated with more severe AKI. To determine the role of 
Pt during the ischemic phase on the development of AKI, we adjusted the Pt by altering 
renal artery pressure. We induced AKI by bilateral clamping of renal veins, and the 
Pt was changed by adjusting the renal artery pressure during the ischemic phase by 
constriction of aorta and mesenteric artery. When we decreased renal artery pressure 
from 85±5 to 65±8 mmHg, Pt decreased from 53.3±2.7 to 44.7±2.0 mmHg. Plasma  
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creatinine decreased from 2.48±0.23 to 1.91±0.21 mg/dl at 24 hours after renal 
ischemia. When we raised renal artery pressure to 103±7 mmHg, Pt increased to                                                                                               
67.2±5.1 mmHg. Plasma creatinine elevated to 3.17±0.14 mg/dl 24 hours after renal 
ischemia. Changes in KIM-1, NGAL and histology were in the similar pattern as plasma 
creatinine. In summary, we found that higher Pt during the ischemic phase promoted the 
development of AKI, while lower Pt protected from kidney injury. Pt may be a potential 
target for treatment of AKI. 
 
Introduction 
Acute kidney injury (AKI) is a syndrome characterized by an abrupt reduction in 
kidney function (Abuelo 2007, Thadhani et al. 1996), resulting in failure to maintain fluid, 
electrolyte and acid-base homeostasis and retention of nitrogenous waste products 
(Bauerle et al. 2011, Mehta et al. 2007). AKI occurs in about 5% of all hospital 
admissions and is responsible for approximately 2 million deaths annually worldwide 
(Murugan & Kellum 2011). AKI increases the risk of development of CKD (Chawla et al. 
2011, Chawla & Kimmel 2012), exacerbates preexisting CKD, and can evolve into end-
stage renal disease (ESRD) (Wald et al. 2009). Patients who survive an episode of AKI 
have poorer long-term outcomes with increased mortality and extensive morbidity (Ali et 
al. 2007). Even though AKI is extensively studied, unfortunately, there is no approved 
therapy to prevent or treat AKI (Jo et al. 2007). Therefore, further understanding of the 
pathophysiological mechanism is crucial to develop therapeutic approaches for AKI. 
Renal ischemia reperfusion is a common cause of AKI (Bonventre & Yang 2011, 
Liano & Pascual 1996, Munshi et al. 2011). Following ischemia reperfusion, tubular 
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epithelial cells undergo serious damage, such as apical brush border disruption, 
swelling, detachment from the basement membrane, and even death with acute tubular 
necrosis, resulting in rapid loss of kidney function (Bonventre & Yang 2011, Devarajan 
2006, Munshi et al. 2011). Several factors, such as hypoxia induced depletion 
(Andreucci et al. 2003, Leemans et al. 2005, Ma et al. 2014), the imbalance between 
superoxide (Masztalerz et al. 2006) and nitric oxide (Chatterjee et al. 2002, Tripatara et 
al. 2007, Walker et al. 2000), and  the inflammatory response have been demonstrated 
to play important roles in renal ischemia reperfusion injury (Patschan et al. 2012, 
Thurman 2007, Tripatara et al. 2007). However, the pathophysiological mechanisms of 
AKI are complicated and are not well elucidated. This is especially true regarding the 
role of hemodynamic alterations and changes in mechanical force in the development of 
AKI. 
The commonly used AKI models induced by occlusions of renal blood flow are 
typically accomplished by clamping of the renal artery, pedicle (artery and vein) or vein. 
Previous studies have reported that renal vein or pedicle clamping produced more severe 
AKI than renal artery clamping alone, but the mechanism remains to be determined (Li et 
al. 2012, Liano & Pascual 1996, Orvieto et al. 2007). In the present study, we tested our 
hypothesis that increased intratubular pressure of the proximal tubule (Pt) during the 
ischemic phase exacerbates kidney injury and promotes the development of AKI. We first 
measured Pt during the ischemic phase while clamping the arteries, pedicles or veins, 
respectively and found a positive correlation between the Pt and the severity of the AKI. 
To determine whether the Pt during the ischemic phase is a causal factor for the kidney 
injury, we adjusted the Pt by altering the renal artery pressure during clamping of the renal 
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veins. We found that increasing the Pt during the ischemic phase worsens AKI while 
lowering the Pt protects renal function. 
 
Methods 
Animals and experimental protocols: C57BL/6 mice (male, 13-15 weeks old) 
were purchased from Jackson Laboratory and housed in the University of South Florida 
Animal Facility. All protocols were approved by the Institutional Animal Care and Use 
Committee (IACUC) at the University of South Florida, College of Medicine.  
Protocol I: AKI was induced by the occlusion of renal blood flow for 18 min in the 
following three groups: 1) bilateral clamping of the renal arteries (RA group); 2) bilateral 
clamping of the renal pedicles (artery and vein) (RP group); and 3) bilateral clamping of 
the renal veins (RV group). The sham operated group underwent the same surgical 
procedures and time courses as the experimental groups except without occlusion of the 
renal blood flow. 
The mice were anesthetized with pentobarbital (50 mg/kg, I.P.) and placed on a 
temperature-controlled operating table (03-02; Vestavia Scientific, AL, USA). The body 
temperature was monitored and controlled at 36.8-37.2 ° C during surgery with a 
temperature control unit. Both kidneys were exposed through a single abdominal incision. 
The Pt was measured as described below. The bilateral renal arteries, pedicles or veins 
were carefully dissected and clamped with silver clips (FE690K; AESCULAP INC, PA, 
USA) for 18 min.  
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In separate survival experiments, the Pt was not measured. After 18 min of 
clamping, the clips were removed, the wounds were sutured, and the animals were 
allowed to recover for 24 hours to evaluate the renal injury.  
Protocol II: Before clamping the renal veins, the renal artery pressure was adjusted 
as described below. Then AKI was induced with  bilateral clamping of the renal veins for 
18 min as described in Protocol I. The animals were divided into following three groups: 
1) normal renal artery pressurerenal artery pressure (NP group); 2) low renal artery 
pressure (LP group) and 3) high renal artery pressurerenal artery pressure (HP group).  
NP group: The renal artery pressure was not adjusted in this group of mice. The 
mean arterial pressure (MAP) was measured with a femoral artery catheter. 
LP group: The aorta above the renal arteries was partially ligated to lower the renal 
artery pressure during the ischemic phase. The abdominal aorta above the renal arteries 
was then carefully separated from vena cava, and a 30-gauge needle was placed along 
the side of the isolated aorta segment. After a 6-0 suture was tied around the aorta and 
the needle, the needle was carefully removed from the ligature. The MAP was measured 
at the femoral artery. 
HP group: Both the superior mesenteric artery and the aorta below the renal 
arteries were partially ligated by using a 30-gauge needle before clamping the renal veins 
to raise the renal artery pressure during the ischemic phase.  This technique was similar 
the to steps described in the LP group. The MAP was measured at the carotid artery.  
In the non-survival experiments, the Pt was measured as described below after 
adjusting the renal artery pressure in the NP, LP and HP groups. In the survival 
experiments, the Pt was not measured. The clips and ligature were removed after 18 min 
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of  ischemia, and the wound was closed. The mice were allowed to recover for 24 hours 
to evaluate the renal injury. 
The proximal tubular pressure (Pt) during the ischemic phase was measured 
using micropuncture as we previously described (Fu et al. 2012, Lu et al. 2015). The 
Mice were anesthetized with pentobarbital (50 mg/kg, I.P.). A tracheostomy was 
performed to facilitate breathing. The femoral artery or carotid artery were catheterized 
for blood pressure measurements. The femoral vein was catheterized for infusion of 
saline with 1% bovine serum albumin (1 ml/hr/100g body weight). Following an 
abdominal incision, the left kidney was exposed and immobilized in a kidney holder cup 
(03-12; Vestavia Scientific, AL, USA). The kidney orientation was positioned so that the 
superficial tubules could be clearly visualized under the microscope (SZX16; Olympus, 
Tokyo, Japan). A long superficial proximal tubule was punctured by a micropipette, 
which connected with a micropressure system (Model 900A; World Precision 
Instruments, FL, USA). The Pt was measured and recorded during the ischemic phase 
while clamping the renal veins.  
The mice were anesthetized again with isoflurane 24 hours after renal ischemia 
for measuring kidney injury markers. The blood samples (100 µl) were collected through 
the retro-orbital venous sinus and centrifuged at 8000 rpm for 5 minutes at 4˚C. Plasma 
samples (50 µl/each) were obtained for creatinine, Kidney injury molecule-1 (KIM-1) and 
Neutrophil gelatinase-associated lipocalin (NGAL) measurements. The creatinine 
concentration was measured by HPLC at the O’Brien Center Core of the University of 
Alabama at Birmingham. The KIM-1 was measured with a Mouse KIM-1 Immunoassay 
Quantikine ELISA KIT and the NGAL was measured with a Mouse NGAL Immunoassay 
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Quantikine ELISA KIT (R&D System, MN, USA), following the manufacturer’s 
instructions.  
The kidneys were harvested and fixed in 4% paraformaldehyde solution 24 hours 
after AKI. Fixed kidney tissues were embedded in paraffin, and 4 µm kidney tissue 
slices were cut and stained with Periodic Acid Schiff (PAS). Ten randomly chosen fields 
were captured under 200x magnification from the cortex, corticomedullary region 
(CMR), outer medulla (OM) and inner medullar (IM), respectively. The percentage of 
necrotic tubules and obstructed tubules by casts in each image was quantified as 
reported (Muroya et al. 2015, Pegues et al. 2013). All morphometric analyses were 
performed in a blinded manner.  
The effects of interest were tested using a Student’s paired t-tests, or two-factor 
analysis of variance (ANOVA) with repeated measures when appropriate. Data were 
presented as mean ± SEM. The changes were considered to be significant if the p-
value was <0.05. 
 
Results 
Protocol I: The Pt was measured for 2 min before occlusion of the renal blood 
flow and during 18 minutes of ischemia in the RA, RP and RV groups. The Pt at 
baseline was about 10 mmHg, increased to 38.4±3.6 mmHg in the RP group (P<0.01 
vs. RA group), to 53.3±2.7 mmHg in the RV group (P<0.01 vs. RP group), and 
decreased to 3.2±2.1 mmHg in the RA group at the end of 18 min of ischemia. The Pt in 
the sham group was constant at about 10 mmHg throughout the experiment (Figure 2A) 
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(P<0.05 vs. the RA, RP and RV groups). During the ischemic phase, the MAP was not 
significantly different between groups (Figure 2B).  
Tubular pressure in proximal tubule were measured using micropuncture. A) The 
difference of proximal tubular pressure during 18 min ischemic phase while clamping 
renal arteries (RA), renal pedicles (RP) and renal veins (RV). B) The mean arterial 
pressure during the ischemic phase in all groups of protocol I. (n=10) *P<0.01 vs Sham 
group; #P<0.01 vs RA group; &P<0.01 vs RP group. C) Proximal tubular pressure during 
18 min ischemic phase while ligating renal pedicles. (n=3). 
 
To exclude the possibility of incomplete occlusion of the renal blood flow by 
clamping, we tightly ligated the renal pedicles with 6-0 suture and then measured the Pt 
during the ischemic phase. The Pt increased from 9.2±1.4 to 35.7±3.3 mmHg over 18 min 
(Figure 2C).  
Figure 2. Proximal tubular pressure. 
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Figure 3. Kidney injury markers after renal ischemia. 
Plasma creatinine (A), plasma KIM-1 (B) and plasma NGAL (C) were measured and 
compared 24 hours after renal ischemia while clamping renal arteries (RA), renal 
pedicles (RP) and renal veins (RV). (n=5) *P<0.01 vs Sham group; #P<0.05 vs RA 
group; &P<0.05 vs RP group. 
 
The plasma creatinine, KIM-1, and NGAL were measured 24 hours after renal 
ischemia. The plasma creatinine was substantially increased in all three AKI groups 
compared with the sham group 24 hours after renal ischemia (P<0.01 vs. sham group).   
The RV group was  the highest (2.48±0.23 mg/dl) (P<0.01 vs. RP group), followed by the 
RP group (1.43±0.19 mg/dl) (P<0.01 vs. RA group) and the RA group (0.45±0.07 mg/dl) 
31 
 
(Figure 3A). The plasma KIM-1 and NGAL had similar patterns as the creatinine (Figure 
3B and 3C).  
The histology of the kidney slices stained by PAS at 24 hours after IR was 
examined among the different groups of animals. The RV mice showed the most severe 
tubular injury with the largest incidence of tubular obstruction by casts and tubular 
necrosis (P<0.01 vs. RP and RA groups, Figure 4A), followed by the RP mice (P<0.05 
vs. RA group) and the RA mice (Figure 4B and 4C). 
Protocol II: The MAP was 85±5 mmHg in the NP group. It decreased to 65±8 
mmHg after partially ligating the aorta above the renal arteries in the LP group and 
increased to 103±7 mmHg after partially ligating both the superior mesenteric artery and 
the aorta below the renal arteries in HP group. To determine whether the Pt was altered 
by adjusting the renal artery pressure during the ischemic phase, we measured the Pt 
during 18 minutes of ischemia in the NP, LP and HP groups. Clamping of the renal 
veins increased the Pt to 53.3±2.7 mmHg in the NP group at the end of 18 min of 
ischemia (Figure 5A). When the renal artery pressure decreased in the LP group, the Pt 
decreased to 44.7±2.0 mmHg (P<0.01 vs. NP group). When the renal artery pressure 
increased in the HP group, the Pt increased to 67.2±5.1 mmHg at the end of 18 min of 
ischemia (Figure 5B) (P<0.01 vs. NP group). To determine whether the Pt during the 
ischemic phase had any effect on  renal injury, we measured kidney injury markers 24 
hours after renal ischemia. The plasma creatinine was 2.48±0.23 mg/dl in the NP group; 
it decreased to 1.91±0.21 mg/dl in the LP group (P<0.05 vs. NP); and increased to 
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3.17±0.14 mg/dl in the HP group (Figure 6A) (P<0.05 vs. NP). The plasma KIM-1 and 
NGAL were similar in pattern as the plasma creatinine (Figure 6B and 6C). 
Figure 4. Histology. 
Histology by PAS staining showed slices of cortex, corticomedullary region (CMR), outer 
medulla (OM) and inner medulla (IM) (A). Kidney injury was quantitatively measured by 
percentage of tubular necrosis (B) and obstructed tubules by casts (C) in the cortex, CMR, 
OM and IM in AKI groups by clamping renal arteries (RA), renal pedicles (RP) and renal 
veins (RV). (n=5) #P<0.05 vs RA group; &P<0.05 vs RP group. Quantitative analysis was 
performed on ten randomly chosen fields in each kidney tissue slice. 
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Tubular pressure in proximal tubule were measured using micropuncture. A) Image of 
the proximal tubular pressure while clamping renal vein with normal renal artery 
pressure (NP), low renal artery pressure (LP) and high renal artery pressure (HP) in 
protocol II. B) The difference of tubular pressure in proximal tubules during 18 min 
ischemic phase in NP group, LP group and HP group. (n=7) *P< 0.01 vs NP group. 
 
 
 
Figure 5. Proximal tubular pressure. 
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Figure 7A shows the representative histology images from different groups of 
mice. The HP group exhibited the most severe tubular injury with the larger incidence of 
tubular obstruction by casts and tubular necrosis (P<0.01 vs. NP group), while the LP 
group showed the least tubular injury among the 3 groups of mice (Figure 7B and 7C) 
(P<0.05 vs. NP group). 
 
 
Plasma creatinine (A), plasma KIM-1 (B) and plasma NGAL (C) were measured and 
compared 24 hours after renal ischemia while clamping renal veins with normal renal 
artery pressure(NP), low renal artery pressure(LP) and high renal artery pressure(HP). 
(n=6) *P<0.05 vs NP group. 
Figure 6. Kidney injury markers after renal ischemia. 
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Histology by PAS staining showed slices of cortex, corticomedullary region (CMR), 
outer medulla (OM) and inner medulla (IM) (A). Kidney injury was quantitatively 
measured by percentage of tubular necrosis (B) and obstructed tubules by casts (C) in 
the cortex, CMR, OM and IM in AKI groups by clamping renal veins with low renal artery 
pressure(LP), normal renal artery pressure(NP) and high renal artery pressure(HP). 
(n=6) *P<0.05 vs LP group and HP group. Quantitative analysis was performed on ten 
randomly chosen fields in each kidney tissue slice. 
 
 
 
Figure 7. Histology. 
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Discussion 
In the present study, we found a positive association between the Pt during the 
ischemic phase and the severity of AKI in three widely-used models by clamping of the 
renal arteries, pedicles or veins. To determine the role of Pt during the ischemic phase of 
the development of AKI, we adjusted Pt by altering the renal artery pressure while 
clamping the renal veins. We found that increasing the Pt during the ischemic phase 
exacerbates AKI while lowering the Pt protects against kidney injury.    
Tubular biomechanical forces are involved in the regulation of renal tubular 
function and associated with epithelial cell damage. In obstructive uropathy, increased 
intratubular pressure and tubular stretch upregulate TGFβ-1, contributing to 
tubulointerstitial inflammation and fibrosis (Quinlan et al. 2008, Sato et al. 2003). Also, 
cyclical stretch on renal epithelial cells induces apoptosis by activating JNK/SAPK and 
p38 SAPK-2 pathways (Nguyen et al. 2006). However, little is known about the role of 
tubular biomechanical forces in the development of AKI. Renal vein or pedicle clamping 
induced more severe AKI than renal artery clamping, but the mechanisms are elusive 
(Liano & Pascual 1996, Orvieto et al. 2007). We examined whether tubular pressure 
during the ischemic phase plays any significant role in the development of kidney injury. 
AKI was induced with 18 min occlusion of the renal blood flow at 37 ° C in C57BL/6 mice. 
First, we measured the Pt during the ischemic phase in three AKI models. We found that 
clamping of the renal arteries significantly lowered the Pt below the pre-ischemia basal 
level. Occlusion of the renal arteries created cessation of glomerular filtration, resulting in 
a decrease of the Pt. On the contrary, the Pt was significantly elevated to approximate 50 
mmHg by clamping the renal veins. The renal venous occlusion lead to kidney 
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congestion, which increased the glomerular hydrostatic pressure, consequently resulting 
in an increase of the Pt. Surprisingly, clamping of the renal pedicles also significantly 
increased the Pt to approximately 35 mmHg. We confirmed this finding by tightly ligating 
the renal pedicles with a 6-0 suture to exclude the possibility of incomplete occlusion of 
the renal blood flow. Suture ligation of the renal pedicles raised the Pt to a similar level as 
clamping of the renal pedicles. Thus, this phenotype was not due to the incomplete 
occlusion of the renal artery. However, we do not know the exact mechanism for this 
phenomenon, which might result from decreased tubular reabsorption, tubular obstruction 
and continued glomerular filtration induced by residual pressure after clamping of the 
pedicles. To our knowledge, the present study is the first to examine the Pt during the 
ischemic phase. Several previous studies measured the Pt after reperfusion. Arendshorst 
et al. examined the Pt after occlusion of the renal artery in rats for 60 min in an elegant 
study (Arendshorst et al. 1975). They found that at 1-3 hours after reperfusion,  the 
proximal tubules were filled with fluid and dilated; the Pt elevated to about 30 mmHg with 
great heterogeneity (Arendshorst et al. 1975). The Pt measured in the other studies were 
also found to be higher than baseline 1-3 days after IRI- or uranyl nitrate-induced AKI 
(Conger et al. 1984, Eisenbach & Steinhausen 1973, Flamenbaum et al. 1974, Tanner & 
Sophasan 1976). The heterogeneity in the Pt observed in these studies may be due to 
tubular obstructions (Conger et al. 1984, Eisenbach & Steinhausen 1973, Flamenbaum 
et al. 1974, Tanner & Sophasan 1976).  
Although we used the method of Isotope Dilution LC-MSMS to measure creatinine 
in mouse plasma to reduce the background and increase specificity (Takahashi et al. 
2007), we realized the limitation of creatinine as an injury maker in mice, since 50% of 
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the creatinine is eliminated via secretion in the mouse kidney tubules (Eisner et al. 2010, 
Vallon et al. 2012). Therefore, we evaluated kidney injury combined with changes in KIM-
1, NGAL, and histology in these three AKI models. We found that at 24 hours after renal 
ischemia, clamping of the renal veins induced the most severe AKI while clamping of the 
renal arteries induced the least renal injury. These results were consistent with the results 
from previous studies (Liano & Pascual 1996, Orvieto et al. 2007). Therefore, the Pt during 
the ischemic phase in these three models was positively associated with the severity of 
AKI. 
Acute reduction in renal blood flow in various clinical situations, such as in 
hypovolemic shock, some cardiac and abdominal surgeries, cardiac arrest, acute left 
heart failure, and kidney transplantation, etc. is often caused by renal arterial hypo-
perfusion. In such case, the renal artery clamping model should better mimic these clinical 
conditions. Clamping of the renal vein is more consistent with clinical situations of vein 
thrombosis, chronic right heart failure, or severe liver cirrhosis. Even though occlusion of 
both the renal artery and vein is not a typical clinical scenario, clamping of the renal 
pedicle is the most common choice for the rodent AKI models, probably due to the 
technical challenge of isolating murine renal arteries. In consideration of the significant 
difference in renal injury in different models, comparison and interpretation of these 
results should be conducted cautiously. 
To determine the significance of Pt during the ischemic phase of the development 
of AKI, we modulated the Pt by adjusting the renal artery pressure while clamping the 
renal veins. To adjust the renal artery pressure, we constricted the aorta and mesenteric 
artery, rather than clamp them to avoid ischemic injury of tissues supplied by the  aorta 
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and mesenteric artery. Constriction of the aorta above the renal arteries lowered the renal 
artery pressure, which led to a decrease in the Pt compared with the normal renal artery 
pressure group. On the contrary, constriction of the aorta and the superior mesenteric 
artery raised the renal artery pressure, which resulted in an increase in the Pt. The kidney 
injury markers were compared at 24 hours after renal ischemia. Mice with a lower Pt in 
the ischemic phase exhibited less renal injury than mice with a normal Pt, while mice with 
an elevated Pt showed more severe renal injury. Therefore, these results suggested that 
Pt during the ischemic phase contributes to the development of AKI. A lower Pt in the 
ischemic phase protects against the development of AKI, while a higher Pt aggravates 
the progression of AKI. Under physiological conditions, renal autoregulation maintains the 
renal blood flow and GFR relatively constant, despite fluctuations in the arterial blood 
pressure over a range  of about 80-160 mmHg.  This buffers the transmission of 
alterations in the arterial blood pressure into the renal tubules (Carlstrom et al. 2015, 
Loutzenhiser et al. 2006). However, ischemia may impair this auto-regulatory capacity, 
resulting in the loss of independent stability in tubular dynamics, thereby permitting the 
arterial pressure transmitted to the intra-glomerulus and tubules (Adams et al. 1980, Guan 
et al. 2006). 
In summary, we found that the severity of AKI from clamping of the  renal arteries, 
veins or pedicles is positively associated with the Pt during the ischemic phase. 
Furthermore, we demonstrated that elevations of the Pt during the ischemic phase by 
increasing the renal artery pressure promotes the development of AKI, while decreasing 
the Pt protects renal function. These findings not only provide novel insight into the 
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mechanisms of AKI but also suggest that modulation of the Pt might be a potential 
approach for the treatment of AKI.  
 
Project II: the role of tubuloglomerular feedback in ischemia reperfusion injury 
induced acute kidney injury 
 
Introduction 
Urine pH in healthy individuals fluctuates over the entire physiological range of 
values from 4.5 -8.5 (Bilobrov et al. 1990). Urine pH in each individual demonstrates 
marked variations throughout the day, but with patterns. A nocturnal peak in urine pH 
was usually seen around 22:00. Throughout the night, urine pH decreased to a nadir 
around 06:00 before rising again in the morning (Ayres et al. 1977, Barnett & Blume 
1938, Cameron et al. 2012, ELLIOT et al. 1959, Jones 1843, Kanabrocki et al. 1988, 
MILLS & STANBURY 1951, STANBURY & THOMSON 1951). Diet can markedly 
affect acid-base status. Dietary acid load has been found to be associated with serum 
bicarbonate levels and urine pH (Gunn et al. 2013, Ikizler et al. 2015, Remer & Manz 
1995). The European Prospective Investigation into Cancer and Nutrition study 
analyzed 22,034 men and women and compared casual urine samples with dietary acid 
load. They found that dietary acid-base load was significantly related to urine pH. 
Casual urine pH provides a simple tangible measure of dietary acid load (Welch et al. 
2008). A recent study reported that urine pH is sensitive to reflect dietary acid-base load 
and reach a steady state in about 3 days (Kanbara et al. 2012).  
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Ischemia and reperfusion are natural steps during kidney procurement and 
transplantation. Transplanted organs experience several episodes of IRI, which can be 
caused by both warm and cold ischemia. Warm ischemia occurs after cardiac death in 
donors, or during harvesting operation from living donors, and during anastomosis of 
the graft. Cold ischemia occurs during allograft kidney storage in organ preservation 
solutions (Homer-Vanniasinkam et al. 1997, O'Callaghan et al. 2012, Opelz & Dohler 
2007, Ploeg et al. 1988, Southard et al. 1985). Post-transplant renal injury has been 
studied extensively (Gulec et al. 2006, Land 1999, Massberg & Messmer 1998, 
Racusen et al. 1999, Sis et al. 2010). Prolonged ischemia increases the occurrence of 
delayed graft function and worsens long-term graft survival (Boom et al. 2000). IRI is 
one of the most important nonspecific factor affecting both delayed and late allograft 
dysfunction (Halloran et al. 1988, Jassem & Heaton 2004, Womer et al. 2000). IRI-
induces AKI has been found crucial for transplanted kidney survival. Recently AKI and 
graft survival of renal transplant recipients has been analyzed in a large retrospective 
cohort study included 27,232 patients. Patients who developed AKI had an increased 
risk of graft loss and an increased risk of mortality (Mehrotra et al. 2012). 
In the present study, we aimed to determine 1) the TGF responsiveness change 
and the alteration of NOS1β activity and expression in the macula densa in IRI-induced 
AKI; 2) the effect of renal pH on TGF response and the activity and expression of 
NOS1β in the macula densa; and 3) the effect of bicarbonate treatment on the 
development of IRI-induced AKI. 
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Methods 
Protocol I: The C57BL/6 mice were induced IRI and then measured 1) 
expression level of NOS1β; 2) TGF response in vivo with micropuncture; 3) GFR in 
conscious mice; and 4) plasma creatinine. Protocol II: The C57BL/6J mice were divided 
into three groups treated with either 0.5% NaCl, 0.72% NaHCO3 (same mEq of Na+ as 
in NaCl) or 0.46% NH4Cl (same mEq of Cl- as in NaCl) for two weeks. The treated mice 
were measured 1) urine pH; 2) expression level of NOS1β; 3) TGF response in vivo with 
micropuncture; and 4) GFR in conscious mice.  
To investigate the role of bicarbonate-induced tubular pH alterations on TGF 
responsiveness, we performed experiments and measured TGF response both in vitro 
and in vivo in response to acute tubular pH changes.  
To determine the role of pH alterations on NOS1 activity, we measured NOS1α 
and NOS1β activity in response to pH changes.  
Protocol III: Both C57BL/6J mice and macula densa specific NOS1 knockout mice (MD-
NOS1KO mice) were induced IRI and then divided into two groups fed a diet containing 
either 0.4% NaCl or 0.4 g/kg NaCl plus 4.3 g/kg NaHCO3 (same Na+ as in 0.4% NaCl 
diet) for 7 days. The mice were measured 1) expression level of NOS1β; 2) GFR in 
conscious mice; and 3) plasma creatinine. 
C57BL/6 mice were anesthetized with pentobarbital (50 mg/kg, I.P.) and placed 
on a temperature-controlled operating table (03-02; Vestavia Scientific, AL, USA). The 
body temperature was monitored and controlled at 36.8-37.2 ° C during surgery with the 
temperature control unit. Both kidneys were exposed through a single abdominal 
incision. Bilateral renal arteries were carefully dissected and clamped by the silver clips 
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(FE690K; AESCULAP INC, PA, USA) for 18 min. After 18 min of clamping, the clips 
were removed, the wounds were sutured, and the animals were allowed to recover for 
24 hours to evaluate renal injury. Sham operated animals without clamping renal 
arteries will be used as control (n=10/group).  
After kidney IRI, we measured 1) expression level of NOS1β and NO generation 
in the macula densa; 2) TGF response in vivo with micropuncture and in vitro in isolated 
perfused JGAs; 3) GFR in conscious mice; and 4) plasma creatinine and histology.      
GFR was measured by the plasma FITC-sinistrin clearance with a single bolus 
injection in conscious mice before cold IRI and 7 days after cold IRI as we previous 
described with modifications (Schreiber et al. 2012, Wang et al. 2016). Briefly, mice 
were injected with FITC-sinistrin solution (5.6 mg/100 g BW) through the retro-orbital 
venous sinus. Blood (<10 µl ) was collected into heparinized capillary tubes through the 
tail vein at 3, 7, 10, 15, 35, 55, and 75 minutes after sinistrin injection. The blood 
samples were centrifuged at 8000 rpm for 5 minutes at 4˚C. Plasma (1 µl) was collected 
from each sample. FITC-sinistrin concentration of the plasma was measured using a 
plate reader (Cytation3; BioTek, VT, USA) with 485-nm excitation and 538-nm emission. 
GFR was calculated with a GraphPad Prism 6 (GraphPad Software).  
Similar method for micropuncture was used as we previously described.(Fu et al. 
2012, Fu et al. 2013) Briefly, mice were anesthetized with inactin (80 mg/ml, I.P.) and 
ketamine (50 mg/ml, I.M.). A tracheostoma was placed to facilitate breathing and 
femoral artery was catheterized for blood pressure measurement. The femoral vein was 
catheterized for infusion of saline with 1% BSA (1 ml/hr/100g body weight). Following an 
abdominal incision, the left kidney was exposed and immobilized in a kidney holder cup. 
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The kidney orientation was positioned so that superficial tubules could be clearly 
visualized under the microscope (SZX16, Olympus, Tokyo, Japan). Tubular flow of a 
selected proximal tubule with multiple visible loops was obstructed with a grease block. 
Stop-flow pressure (Psf) in proximal tubule upstream of the grease block was measured 
with servo-nulling method (Model 900A; World Precision Instruments, FL, USA). 
Micropipette for pressure measurement with a tip diameter at 2-5 µm was filled with 2 M 
KCl colored with 1% fast green. Proximal tubule distal to the grease block was perfused 
with artificial tubular fluid (ATF, containing 4 NaHCO3, 5 KCl, 2 CaCl2, 7 urea, 2 MgCl2, 
128 NaCl, and 1% fast green in mM; pH 7.4). Psf was measured when tubular perfusion 
rate was set at 0 nl /min and 40 nl/min for 3-5 min. The change of Psf (ΔPsf) was used as 
an index of TGF response mediated vasoconstriction in afferent arteriole (Fu et al. 
2012).  
TGF in vivo measured in isolated double-perfused JGA as described reports (Liu 
et al. 2004b, Zhang et al. 2013). The mice were anesthetized with inhaled isoflurane 
and the kidneys were removed and sliced. Kidney slices were placed in ice cold DMEM 
containing 5% BSA and dissected under a stereomicroscope (model SMZ 1500; Nikon). 
An intact JGA was microdissected under a stereomicroscope. The dissected JGA was 
transferred to a temperature controlled chamber mounted on an inverted microscope. 
The Af-Art was cannulated with glass micropipette and perfused with dulbecco’s 
modified eagle’s medium-low glucose (DMEM), and intraluminal pressure was 
maintained at 60 mmHg throughout the experiment. The end of tubule was cannulated 
with another glass micropipette and perfused with the macula densa solution containing 
either 80 NaCl (high NaCl) or 10 NaCl (low NaCl). The pH of the solution was 7.4. Once 
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the JGA was double perfused and temperature in bath solution was gradually increased 
to 37°C for 30 min, we induced a TGF response by increasing tubular perfusate NaCl 
concentration from 10 to 80 mM by measuring maximal constriction of the Af-Art. Time 
control was performed using the same protocol and time course except without tubular 
NaCl concentration (n=10/group). 
Rabbits (It is difficult to do double perfusion in mice.) were anesthetized with 
ketamine (50 mg/kg, I.M.) and kidneys were removed and sliced. Kidney slices were 
placed in ice cold DMEM containing 5% bovine serum albumin. A single superficial 
intact glomerulus was microdissected together with adherent tubular segments 
consisting of the TAL, macula densa, and early distal tubule under a stereomicroscope 
(SMZ1500, Nikon, Yuko, Japan) as described previously (Liu et al. 2004a). The 
dissected sample was transferred to a temperature controlled chamber mounted on an 
inverted microscope (Axiovert 100TV, ZEISS, NY, USA). The glomerulus was hold with 
glass pipette. The TAL was cannulated and perfused with another glass pipette with a 
macula densa solution containing: 10 HEPES, 1.0 CaCO3, 0.5 K2HPO4, 4.0 KHCO3, 1.2 
MgSO4, 5.5 glucose, 0.5 Na acetate, 0.5 Na lactate, and 10 NaCl in mM; pH 7.4. For 
NO measurement, the macula densa was loaded with a fluorescent NO probe 4-amino-
5-methylamino-2', 7’-difluorofluorescein diacetate (DAF-2 DA; 10 μM plus 0.1% pluronic 
acid) from the tubular lumen for 30 min, then washed for 10 min with macula densa 
solution. DAF-2 was excited at 490 nm with a xenon light, and the emitted fluorescence 
was recorded at wavelengths of 510 to 550 nm. The rate of increase in fluorescent 
intensity of DAF-2 was used to determine NO generation by the macula densa as we 
previously described.(Fu et al. 2012, Wang et al. 2015) We measured TGF-induced NO 
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generation by the macula densa when we switched the tubular perfusate from 10 to 80 
mM NaCl. Then we switched the tubular solution back to 10 mM NaCl , added NOS1 
inhibitor 7-NI (10-4M) to tubular perfusate and perfused for 20 min. TGF-induced NO 
generation was measured again after we increased tubular NaCl to 80 mM in the 
presence of 7-NI. Time control was performed using the same protocol and time course 
except without 7-NI. 
Protein was extracted from renal cortex. Protein extracts (50 μg/lane) were 
subjected to 12 % SDS-PAGE separation. After blocking for 30 min at room 
temperature with 5% skim milk, the membranes were incubated overnight at 4 °C with 
NOS1 antibody (mouse polyclonal, IgG; 1:3000; BD Biosciences, CA, USA). After 
incubation of the membranes with horseradish peroxidase-conjugated secondary 
antibody (goat anti-mouse,IgG;1:300,000;Bio-R, CA, USA), the antibody-reactive bands 
were revealed by enhanced chemiluminescence detection on Hyperfilm (Amersham 
Pharmacia Biotech, Piscataway, NJ) and band density was determined using the public 
image program. 
The mice were placed in metabolic cages for 24 hours. Urine will be collected for 
measurement of pH. 
The mice were anesthetized again with isoflurane 24 hours and 7 days after cold 
IRI. The blood samples (100 µl/each) were collected through the retro-orbital venous 
sinus and centrifuged at 8000 rpm for 5 minutes at 4˚C. The plasma (50 µl/each) was 
obtained for creatinine measurement. Creatinine concentration was measured by HPLC 
at the O’Brien Center Core of the University of Alabama at Birmingham.  
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To determine the role of pH alterations on NOS1 activity, NOS1α and NOS1β 
activity were measured with different pH condition (5.6, 6, 6.5, 7, 7.4, 7.9 and 8.3) by 
using Nitric Oxide Synthase (NOS) Activity Assay Kit (Biovision, Zurich, Switzerland) 
following the manufacturer’s instruction. The NOS1α and NOS1β protein sample were 
extracted through cell transfection. Vectors of NOS1α and NOS1β were kindly provided 
by Dr. Dieter Saur from Technical University of Munich in Germany (Saur et al. 2002). 
The pH value of the protein sample was adjusted by adding either HCl or NaOH and 
measured by using orion micro pH electrode (Thermo Scientific, MA, USA). 
Results 
Protocol I: To determine whether renal IRI decreases expression of NOS1β in the 
macula densa, we compared NOS1β expression in renal cortex between IRI and sham 
operated mice. In renal cortex, NOS1β level decreased by 84±6% in IRI mice compared 
with sham operated mice (n=6, p<0.01 vs sham, Figure 8A and 8B). 
To determine whether renal IRI enhance TGF response in vivo, TGF response 
was measured right after and 7 days after IRI. Right after IRI, Psf was from 32.2±4.5 to 
31.4±3.8 mmHg when perfusion rate was increased stepwise from 0 to 40 nL/min (n=4). 
TGF response which was measured by maximal change of Psf was 0.8±0.6 mmHg. In 
separate experiments, we measured TGF response in the mice 7 days after IRI and 
found TGF increased to 7.2±0.8 mmHg (n=5, p<0.01 vs right after IRI). TGF response in 
sham operated mice was 4.7±0.5 mmHg right after operation (n=3) and 4.1 ±0.3 mmHg 
7 days after sham operation (n=3, p<0.01 vs IRI, Figure 9). 
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NOS1β expression in renal cortex were measured and compared between IRI and 
sham operated mice. A) Representative Image of NOS1β Expression after IRI (n=8); B) 
NOS1β level decreased by 84±6% in IRI mice compared with sham operated 
mice.*p<0.01 vs sham. 
TGF response was measured right after and 7 days after IRI. TGF response was 
0.8±0.6 mmHg right after IRI and increased to 7.2±0.8 mmHg 7 days after IRI,. #p<0.01 
vs right after IRI; *p<0.01 vs Sham. 
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Figure 8. NOS1β protein level. 
Figure 9. TGF response in vivo. 
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GFR in conscious mice were measured before IRI at baseline and 7 days after IRI. GFR 
in the sham operated mice had no significant decrease 7 days after surgery. However, 
the GFR decreased by 21.6±1.9% in IRI mice compared with the sham operated mice. 
*p<0.01 vs Sham. 
 
To determine whether renal IRI decrease GFR, we measured GFR in conscious 
mice before IRI at baseline and 7 days after IRI. Baseline GFR was similar between IRI 
and sham operated mice. GFR in the sham operated mice had no significant decrease 7 
days after surgery. However, the GFR decreased by 21.6±1.9% in IRI mice compared 
with the sham operated mice (n=6, p<0.01 vs Sham, Figure 10). Plasma creatinine was 
measured 24 hours and 7 days after IRI to evaluate kidney injury. At 24 hours after IRI, 
the plasma creatinine was 0.08±0.03 mg/dl in sham operated mice and increased to 
0.45±0.07 mg/dl in IRI mice. At 7 days after cold IRI, the plasma creatinine was still 
significantly higher in IRI mice compared with sham operated mice (n=6, p<0.01 vs Sham, 
Figure 11). 
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Figure 10. GFR after IRI. 
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Plasma creatinine was measured 24 hours and 7 days after IRI. *p<0.01 vs Sham. 
 
 
Protocol II: To determine whether changes of pH alter NOS1 activity in renal 
cortex, NOS1α and NOS1β activity were measured with different pH value (5.6, 6, 6.5, 
7, 7.4, 7.9 and 8.3), separately. NOS1β activity was 0.3865±0.0477 mU/mg when pH 
value was 7.4. It gradually decreased in response to the decrease of pH value. 
However, NOS1β activity reached its peak value (0.4492±0.0199 mU/mg) when pH was 
7.9. NOS1α activity was 0.3912±0.0268 mU/mg when pH value was 7.4 and increased 
to 0.4666±0.0368 mU/mg when pH value decreased to 6.5 (Figure 12).   
We measured TGF response in vitro in isolated and double perfused JGA. When 
we switched the tubular perfusate from 10 to 80 mM NaCl solution with a pH adjusted to 
7.4, the Af-Art constricted from 16.1±0.7 to 12.5±0.5 µm µm. The difference in diameter 
between 80 and 10 mM NaCl is a TGF response, which was 3.6 ± 0.3 µm. Then we 
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Figure 11. Plasma creatinine after IRI. 
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switched the tubular solution back to 10 mM NaCl for 15 min and pH of tubular perfusate 
was adjusted to 8.4. When we increased tubular NaCl to 80 mM, the Af-Art constricted 
from 17.3±0.6 µm to 14.5± 0.7 µm. TGF was reduced by 2.8 ± 0.2 µm (p<0.05, n=5, 
Figure 13A), indicating that TGF was blunted when pH at the macula densa increased.  
 
NOS1α and NOS1β activity with different pH value. 
 
We measured TGF response in vivo with micropuncture. When we increased 
tubular pH from 5.5 to 8.0, ΔPsf was decreased from 12.4 ± 1.5 at pH 5.5 to 9.9 ± 1.8mmHg 
at pH 8.0 (n=9 tubules/4 rats, p<0.05, Figure 13B). These data demonstrated that 
increases of tubular pH blunted TGF response both in vitro and in vivo. To determine 
whether the effect of tubular pH-induced TGF inhibition is mediated by activation of 
nNOS, we added in LNMA to the tubular perfusate to inhibit NOS and measured TGF 
response. ΔPsf was 11.1 ± 1.4 mmHg at pH 5.5 and 13.0± 1.6 mmHg at pH 8.0, 
respectively (n=7 tubules/4 rats, Figure 13C). LNMA eliminated the pH-induced TGF 
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Figure 12. NOS1 activity. 
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inhibition when increasing tubular pH from 5.5 to 8.0. These data indicated that the 
increases of tubular pH blunted TGF response mediated by enhancing NO generation. 
A) Increase of pH at the macula densa blunts TGF isolated double-perfused JGA. *p<0.05 
vs pH 7.4. B) Increase of tubular pH blunts TGF response in vivo. *p<0.05 vs pH 5.5. C) 
LNMA Eliminated the pH Induced TGF Inhibition when Increasing Tubular pH. 
 
Figure 13. TGF response in response to acute tubular pH changes. 
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To determine whether high bicarbonate intake increase urine pH, we measured 
pH in urine collected with metabolic cages. Urine pH was significantly increased to 
7.9±0.3 in NaHCO3 treated group and decreased to 6.5±0.2 in NH4Cl treated group, 
compared with the NaCl treated group (7.1±0.3) (n=5, p<0.05, Figure 14). 
 
To determine whether high bicarbonate intake increase renal NOS1β expression, 
the expression of NOS1β in renal cortex was measured and compared in NaHCO3, 
NH4Cl and NaCl treated mice. The NOS1β protein was significantly increased with a 
more than 5 folds higher in NaHCO3 treated group than that in NaCl treated group. On 
the contrary, NOS1β level was significantly decreased in NH4Cl group with about 1/3 
value of that in NaCl group (n=4, p<0.05, Figure 15A and 15B). 
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Figure 14. Urine pH. 
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The protein level of NOS1β was compared in NaHCO3 treated, NaCl treated and NH4Cl 
treated mice. The NOS1β protein was significantly increased with a more than 5 folds 
higher in NaHCO3 treated group than that in NaCl treated group. On the contrary, 
NOS1β level was significantly decreased in NH4Cl group with about 1/3 value of that in 
NaCl group. *p<0.01 vs NaCl group. 
 
To determine whether high bicarbonate intake inhibited TGF response, TGF 
response was measured and compared in NaHCO3, NH4Cl and NaCl treated mice. TGF 
was significantly blunted to 3.1±0.5 mmHg in NaHCO3 group but significantly enhanced 
to 7.4±0.8 mmHg in NH4Cl group, compared with NaCl group (4.4±0.7 mmHg) (n=4 
mice/10 tubules, p<0.05 vs NaCl group, Figure 16).  
 
 
 
Figure 15. The effect of bicarbonate on NOS1β expression. 
55 
 
TGF was measured and compared in NaHCO3 treated, NaCl treated and NH4Cl treated 
mice. *p<0.05 vs NaCl group. 
 
To determine whether increased bicarbonate intake raise GFR, GFR was 
measured and compared in NaHCO3, NH4Cl and NaCl treated mice. There was no 
significant difference among three groups, which was 237.6±13.7 μl/min in NaHCO3 
treated mice, 229.5±17.2 μl/min in NH4Cl treated mice and 241±12.8 μl/min in NaCl 
treated mice (n=5, Figure 17). 
GFR was measured and compared in NaHCO3, NH4Cl and NaCl treated mice. 
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Figure 16. TGF response in vivo after high bicarbonate intake. 
Figure 17. GFR in conscious mice after high bicarbonate intake. 
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Protocol III: To determine whether bicarbonate prevent IRI-induced decrease in 
NOS1β expression, the expression of NOS1β in renal cortex was measured and 
compared 7 days after IRI between NaHCO3 and NaCl treated mice. In renal cortex, 
NOS1β protein abundance was 3.6±0.16 times higher in NaHCO3 treated mice than 
that in NaCl treated mice (n=5, p<0.05 vs NaCl group, Figure 18A and 18B). 
A) Representative Image of NOS1β Expression after High Bicarbonate Intake in IRI Mice. 
B) The protein level of NOS1β was compared between NaCl and NaHCO3 treated mice 
after IRI. *p< 0.01 vs sham. 
 
To determine whether bicarbonate prevent IRI-induced decrease of GFR, GFR 
was measured and compared before IRI at baseline and 7 days after IRI between 
NaHCO3 and NaCl treated mice. Baseline GFR was similar between NaHCO3 and NaCl 
Figure 18. NOS1β expression after high bicarbonate intake in IRI mice. 
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treated mice. At 7 days after IRI, GFR increased by 15.8±2.2% in NaHCO3 treated mice 
compared with NaCl treated mice (n=6, p<0.05 vs NaCl group). 
To further determine the role of NOS1β in the alteration of GFR by bicarbonate, 
we measured GFR before IRI at baseline and 7 days after IRI in MD-NOS1KO mice. The 
difference of GFR between NaCl treated (172.5±9.3 μl/min) and NaHCO3 treated mice 
(186.2±10.2 μl/min) was attenuated (n=4, Figure 19). 
GFR was measured and compared before IRI at baseline and 7 days after IRI between 
NaHCO3 and NaCl treated mice. The difference of GFR between NaCl treated (172.5±9.3 
μl/min) and NaHCO3 treated mice (186.2±10.2 μl/min) was attenuated. *p< 0.05 vs 
baseline; *p< 0.05 vs NaCl. 
 
 
Plasma creatinine was measured 7 days after IRI to evaluate kidney injury. At 7 
days after cold IRI, the plasma creatinine was 0.37±0.03 in NaCl treated WT mice and 
decreased to 0.28±0.04 in NaHCO3 treated WT mice (n=6, p<0.05 vs NaCl). However, 
the decrease of plasma creatinine in NaHCO3 treated MD-NOS1KO mice was limited 
compared with NaCl treated MD-NOS1KO mice (n=4, Figure 20). 
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Figure 19. GFR in conscious mice after high bicarbonate intake in IRI mice. 
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Plasma creatinine was measured and compared 7 days after IRI between NaHCO3 and 
NaCl treated mice. The decrease of plasma creatinine in NaHCO3 treated MD-
NOS1KO mice was limited compared with NaCl treated MD-NOS1KO mice. *p< 0.05 vs 
NaCl. 
 
Discussion 
In the present study, we examined 1) the effect of renal pH on TGF response and 
the activity and expression of NOS1β in the macula densa; 2) the TGF responsiveness 
change and the alteration of NOS1β activity and expression in the macula densa in IRI-
induced AKI; and 3) the effect of bicarbonate treatment on the development of IRI-
induced AKI. We found that 1) renal pH modulates TGF response by regulating NOS1β 
in the macula densa; 2) renal IRI downregulates NOS1β in the macula densa and 
enhances TGF response, which promotes the development of AKI; and 3) bicarbonate 
treatment protected against IRI-induced AKI by upregulating NOS1β in the macula 
densa. 
In both humans and experimental animals, reductions in GFR have been 
attributed to persistent vasoconstriction. An intense and persistent renal 
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Figure 20. Plasma creatinine after high bicarbonate intake in IRI mice. 
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vasoconstriction that reduces overall kidney blood flow and GFR has long been 
considered a hallmark of AKI (Lameire et al. 2005, Mason et al. 1977). In fact, ischemic 
AKI has been referred to as “vasomotor nephropathy”. A severe injury of the proximal 
tubular in renal cortex and TAL in the outer medulla is a uniform feature in various forms 
of AKI while the glomeruli are morphologically normal (Heyman et al. 1988, Lieberthal & 
Nigam 1998, Oken 1975, Regner et al. 2009). Tubular injury can also lead to a 
decrease in GFR by tubular obstruction with epithelial debris and backleak. However, 
normal pressures have been observed in several tubules, making it unlikely for tubular 
obstruction to be the singularly important mediator of reduction in GFR after ischemic 
injury (Conger et al. 1984). Arendshorst et al.(Arendshorst et al. 1975) studied severe 
AKI after 1 h of unilateral renal ischemia. They found that in the early stages (1-3 h) 
after ischemia, the pressures in the proximal and distal tubules were elevated, and there 
was histological evidence of tubular obstruction. Tubular obstruction appeared to be the 
predominant factor in the decline in filtration rate at this stage. However, at a later time-
point (22-26 h), tubular pressures were normal, but preglomerular vasoconstriction was 
marked and this was thought to contribute to the persistent decline in filtration rate. In 
addition, tubular obstruction does not appear to be a significant pathogenic mechanism 
in AKI in humans, in which only about 10% decrease in GFR could be explained by 
tubular backleak (Blantz & Singh 2011, Braam et al. 1993, Myers et al. 1979, Schrier et 
al. 2004). A single nephron model of nephrotoxic tubular injury was established by 
microperfusion of uranyl nitrate into the early proximal tubule (Peterson et al. 1989). 
Within minutes of intratubular administration of uranyl nitrate, a 16-30% reduction in 
SNGFR was observed. The local mechanism such as TGF could be invoked to explain 
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the immediate decline in SNGFR. Similar findings have been observed in the uranyl 
nitrate model of AKI by another group (Flamenbaum et al. 1974). Hence, an increase in 
preglomerular resistance appears to be consistent in nearly all forms of AKI and TGF 
has been postulated to dictate the enhanced preglomerular vascular resistance and 
reduction in GFR in AKI (Thurau & Boylan 1976). In present study, we measured TGF in 
vivo with micropuncture right after and 7days after following 18 min clamping of renal 
arteries. The results indicate that renal ischemia impairs TGF response early after IRI, 
but enhances TGF response later after IRI.  
As an enzyme to catalyze the generation of NO and citrulline from L-arginine, 
NOS1 is affected by pH. However, the optimal pH for NOS1 is controversial in previous 
studies. The maximal efficiency of NOS1 was measured at a pH 6.7 with the brain 
tissue (Chen et al. 1997). However, the most favorable pH for NOS1 in the kidney tissue 
was indicated to be around 8.0 (Liu et al. 2004a, Wang et al. 2003a). There are three 
splice variants of NOS1, α, β, and γ. NOS1α is the primary isoform in brain but NOS1β 
is the majority in kidney. Hence, in present study, we generated the distinct NOS1α and 
NOS1β by their expression vectors and measured the activity under conditions with 
graded pH environment. The results indicated that the most favable pH for NOS1α was 
6.5 and the optimium for NOS1β was 7.9, which is consistant of the previous studies 
and explains the controversy. 
In previous studies, we reported that the NO generation was enhanced by the 
macula densa during TGF response (Liu et al. 2004a). The activation of nNOS is 
mediated by elevation of intracellular pH in the macula densa via NHE (Liu et al. 
2004a). Microperfusion studies showed when luminal pH was increased, there was a 
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linear correlation between changes in intracellular pH and extracellular pH in macula 
densa, and intracellular pH of the macula densa at high NaCl was always higher than at 
low NaCl (Liu et al. 2008). Also, in cultured tubular cells decreasing pH in culture 
medium with different concentration of NaHCO3 accordingly reduced intracellular pH 
(Yaqoob et al. 1996). These studies indicate changing luminal pH can be used to alter 
intracellular pH. In our study, it is very likely that modulation of luminal pH took effect by 
altering intracellular pH. During TGF response NO concentration by the macula densa 
increased significantly (Liu et al. 2002). The inhibition of NO generation by either NOS 
blockers (Welch & Wilcox 1997) or specific nNOS inhibitors (Ren et al. 2000b, Welch et 
al. 2000) enhances TGF responsiveness both in vivo and in vitro. We previously found 
that raising intracellular pH of the macula densa from 7.3 to 7.8 significantly increased 
NO concentration in microdissected and perfused macula densa and 7-Nitroindazole 
blocked the increase of NO induced by elevated pH (Liu et al. 2004a). In present study, 
we found tubular pH directly regulate TGF responsiveness at the macula densa in vivo 
with micropuncture and in vitro with microperfusion. Increases of pH in tubules blunt 
TGF response. NOS inhibition eliminated this effect, indicating NO mediated the 
attenuation of TGF induced by elevation of tubular pH.       
Current guidelines for CKD patients recommend alkali treatment with sodium 
citrate or sodium bicarbonate for those with serum total CO2 less than 22 mM (2000). 
Indeed, the correlation between low serum bicarbonate level and progressive decline in 
eGFR has been studied extensively in patients with CKD. Alkali therapy reduces kidney 
injury and slows nephropathy progression in patients with CKD (de Brito-Ashurst et al. 
2009, Dobre et al. 2015, Eustace et al. 2004, Goraya et al. 2012, Kovesdy et al. 2009, 
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Mahajan et al. 2010, Navaneethan et al. 2011, Phisitkul et al. 2010, Raphael et al. 2011, 
Shah et al. 2009, Susantitaphong et al. 2012), but the mechanism is not clear. Diet can 
markedly affect acid-base status and it significantly influences CKD and its 
progression. In the National Health and Nutrition Examination Survey, 11,957 adults 
were analyzed  and found that high serum anion gap values and decreased serum total 
CO2 concentration were associated with increased mortality in the general population 
and with a decline in eGFR in patients with CKD (Abramowitz et al. 2012). In a separate 
study, the correlation between dietary acid load and eGFR were assessed in 12,293 US 
adults. High dietary acid load was found to be associated with albuminuria and low 
eGFR (Banerjee et al. 2014). A cross-sectional study of the African American Study of 
Kidney Disease and Hypertension cohort indicate that a higher acid load and lower total 
serum CO2 concentration (reflects serum bicarbonate concentration) correlate with more 
severe CKD and readily decline of eGFR (Scialla et al. 2011). Oral bicarbonate 
supplementation slows CKD progression in humans (de Brito-Ashurst et al. 
2009). Recent two intervention studies, one in patients with early CKD without metabolic 
acidosis (Goraya et al. 2012), and the other in patients with advanced CKD and 
metabolic acidosis (Goraya et al. 2013), suggest that a diet rich in fruits and vegetables 
can improve renal function and slow the progression of CKD. In patients at risk of CKD, 
alkali-generating diets that are rich in fruits and vegetables reduce the risk of developing 
CKD (Chang et al. 2013, Dunkler et al. 2013, Lin et al. 2011, Nettleton et al. 2008, 
Scialla et al. 2011). Oral bicarbonate supplementation has been found to delay the 
decline of GFR in CKD patients (Dobre et al. 2015, Eustace et al. 2004, Kovesdy et al. 
2009, Navaneethan et al. 2011, Raphael et al. 2011, Shah et al. 2009, Susantitaphong 
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et al. 2012), but the mechanism is not clear. Recently, the relationship between serum 
bicarbonate and GFR has been analyzed in people with normal renal functions. Lower 
serum bicarbonate concentrations are found to be associated independently with rapid 
decline of eGFR in a study of 5422 adults; in a Multi-Ethnic Study of Atherosclerosis of 
5810 participants (Driver et al. 2014), and in a Health, Aging, and Body Composition 
study (Goldenstein et al. 2014). The baseline eGFR of most or all of the participants in 
these studies is above 60 mL/min/1.73 m2. Dietary acid load has also been found an 
important determinant of kidney injury in rat models of CKD with and without metabolic 
acidosis (Khanna et al. 2004, Mahajan et al. 2010, Nath et al. 1985, Phisitkul et al. 
2010, Wesson et al. 2006, Wesson & Simoni 2010). In present study, we measured 
GFR and plasma creatinine 7 days after IRI in bicarbonate treated C57BL/6J and MD-
NOS1KO mice. We found NaHCO3 treatment can limit the decrease of GFR and the 
increase of plasma creatinine in C57BL/6J mice, but this limitation was attenuated in 
MD-NOS1KO mice. The results indicate upregulation of NOS1β in the macula densa by 
a high bicarbonate intake could be a novel mechanism, but also a potential target for 
prevention and treatment for IRI-induced AKI. 
In conclusion, we found 1) renal pH modulates TGF response by regulating 
NOS1β in the macula densa; 2) renal IRI downregulates NOS1β in the macula densa 
and enhances TGF response, which promotes the development of AKI; and 3) 
bicarbonate treatment protected against IRI-induced AKI by upregulating NOS1β in the 
macula densa.
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Project III: the role of renal temperature during the ischemic phase in acute 
kidney injury 
 
Abstract 
Ischemia and reperfusion are natural steps during kidney transplantation, and IRI 
is considered one of the most important nonspecific factors affecting allograft 
dysfunction. Transplanted organs experience several episodes of ischemia, in which 
cold ischemia occurs during allograft storage in preservation solutions. 
Even though cold ischemia has been studied extensively, all of the studies have 
been carried out in vitro and ex vivo models. There is no in vivo model available to 
examine renal IRI induced solely by cold ischemia. 
In the present study, we developed an in vivo mouse model to study renal IRI 
induced exclusively by cold ischemia through clamping the renal pedicle for 1 to 5 
hours. During the ischemic phase, blood was flushed from the kidney with cold saline 
through a small opening on the renal vein. The kidney was kept cold in a kidney cup 
with circulating cooled saline, while the body temperature was maintained at 37℃ during 
the experiment. The level of kidney injury was evaluated by plasma creatinine, KIM-1, 
NAGL, GFR, and histology.  
Plasma creatinine was significantly increased from 0.15±0.04 mg/dl in the sham 
group to 1.14±0.21 and 2.65±0.14 mg/dl in 4 and 5-hours ischemia groups at 24 hours 
after cold IRI. The plasma creatinine in mice with ischemic time <3 hours demonstrated 
no significant increase compared with sham mice. Changes in KIM-1, NAGL, GFR and 
histology were similar to plasma creatinine.   
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In summary, we developed and characterized a novel in vivo IRI-induced AKI 
mouse model exclusively produced by cold ischemia. 
 
Introduction 
Renal transplantation is the best replacement therapy for patients with end-stage 
kidney disease. Not only is kidney transplantation a life-saving procedure, but it also 
improves the patient’s quality of life (Hricik et al. 2001, Kaplan & Meier-Kriesche 2002, 
Murray et al. 1984, Wolfe et al. 1999). 
Ischemia reperfusion injury (IRI) has remained one of the most serious pitfalls of 
the kidney transplantation procedure. IRI-induced acute AKI can crucially affect the 
transplanted kidney’s survival and is considered one of the most important nonspecific 
factors affecting both early and late allograft dysfunction (Nehus & Devarajan 2012). 
Ischemia and reperfusion are natural steps during kidney procurement and 
transplantation. Transplanted organs experience several episodes of IRI, which can be 
caused by both warm and cold ischemia. Warm ischemia occurs after cardiac death in 
cadaveric donors, or during harvesting operations from living donors, and during 
anastomosis of the graft. Cold ischemia occurs during allograft kidney storage in organ 
preservation solutions (Southard et al. 1985), which was invented in 1960’s and is the 
most seminal step to avoid IRI, allowing for safe renal preservation exceeding 24 hours 
(Collins et al. 1969). It remains the mainstay of preservation for kidney allografts 
worldwide (O'Callaghan et al. 2012, Opelz & Dohler 2007). 
Even though cold ischemia has been studied extensively for a long time, all of 
the studies have been carried out in vitro and ex vivo models (O'Callaghan et al. 2012). 
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There is no in vivo model available to examine IRI induced solely by cold ischemia. In 
the present study, we developed a novel in vivo model to study renal IRI induced 
exclusively by cold ischemia. 
 
Methods 
C57BL/6 mice were anesthetized with pentobarbital (50 mg/ml, IP) and their body 
temperature was maintained at 36.8-37.2˚C during surgery with a temperature-
controlled operating table (03-02; Vestavia Scientific, AL, USA). A midline abdominal 
incision was performed. The right pedicle was ligated, and the right kidney was 
removed. The left kidney, aorta and inferior vena cava were exposed (Rong et al. 2012). 
Then, the left kidney was placed in a kidney cup and incubated with cool saline (Figure 
21A and 21B), while the temperature was maintained at 4±0.5°C by circulating sterilized 
saline solution from a saline reservoir on ice, driven with a low flow peristaltic pump 
(P720; Instech Laboratories, PA, USA). Four 5 mm microvascular mini clips (FE690K; 
AESCULAP INC, PA, USA) were used to prevent bleeding and induce ischemia (Figure 
21C) in the following steps: 1) the inferior vena cava and the aorta below the renal 
arteries were clamped together (# 1 clip), and then the aorta above the renal arteries 
was clamped (# 2 clip); 2) the left renal vein near the vena cava was clamped (# 3 clip), 
and a small opening was cut on the left renal vein between clip #3 and the left kidney; 3) 
the aorta between the left renal artery and clip #1 was infused with 1-1.5 mL of 4°C 
0.9% sterilized saline using a 30G needle until the solution from the opening on the 
renal vein cleared and the color of the left kidney became white (Figure 20B); 4) the left 
renal pedicle between the opening and the left kidney was clamped (# 4 clip). Then the 
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small opening was sutured with 10-0 suture (BV75-4; ETHICON, GA, USA); 5) three 
clips (# 1, 3 and 2 clips) on the inferior vena cava, left renal vein and aorta were 
removed, sequentially. The ischemic durations were 1, 2, 3, 4 and 5 hours, respectively. 
The time of ischemia was starting from clamping the aorta with clip #2. The clip on the 
renal pedicle (# 4 clip) and the kidney cup were removed at the end of the respective 
ischemic times. Blood flow was restored. The wounds were sutured, and the mice were 
recovered in an incubator until fully awake. The sham–operated mice underwent 
identical surgical procedures, and the left kidney was incubated with 4±0.5°C sterilized 
saline for 5 hours without ischemia induction as a control group. Twenty-four hours after 
cold IRI, some of the mice in different groups were anesthetized again with isoflurane to 
collect blood samples and kidney tissues as described below. Other mice in different 
groups were kept for 7 days to measure glomerular filtration rate (GFR).  
The mice were anesthetized again with isoflurane 24 hours and 7 days after cold 
IRI for measuring kidney injury markers. The blood samples (100 µl/each) were 
collected through the retro-orbital venous sinus and centrifuged at 8000 rpm for 5 
minutes at 4˚C. The plasma (50 µl/each) was obtained for creatinine, KIM-1, and NGAL 
measurements. Creatinine concentration was measured by HPLC at the O’Brien Center 
Core of the University of Alabama at Birmingham. KIM-1 was measured with a Mouse 
KIM-1 Immunoassay Quantikine ELISA KIT, and NGAL was measured with a Mouse 
NGAL Immunoassay Quantikine ELISA KIT (R&D System, MN, USA), following the 
manufacturer’s instructions.  
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A) The left kidney in a kidney cup and incubated with cool saline. B) The left kidney 
during the ischemic phase. C) Usage image of clips.  
 
 
 
Figure 21. Typical images of the cold ischemia procedure. 
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GFR was measured by the plasma FITC-sinistrin clearance with a single bolus 
injection in conscious mice before cold IRI and 7 days after cold IRI as we previous 
described with modifications (Schreiber et al. 2012, Wang et al. 2016). Briefly, mice 
were injected with FITC-sinistrin solution (5.6 mg/100 g BW) through the retro-orbital 
venous sinus. Blood (<10 µl ) was collected into heparinized capillary tubes through the 
tail vein at 3, 7, 10, 15, 35, 55, and 75 minutes after sinistrin injection. The blood 
samples were centrifuged at 8000 rpm for 5 minutes at 4˚C. Plasma (1 µl) was collected 
from each sample. FITC-sinistrin concentration of the plasma was measured using a 
plate reader (Cytation3; BioTek, VT, USA) with 485-nm excitation and 538-nm emission. 
GFR was calculated with a GraphPad Prism 6 (GraphPad Software). 
The kidneys were harvested and fixed in 4% paraformaldehyde solution 24 hours 
after cold IRI. Fixed kidney tissues were embedded in paraffin, and 4 µm kidney tissue 
slices were cut and stained with PAS. Ten randomly chosen fields were captured under 
400x magnification from the cortex, CMR, OM and IM respectively. The percentage of 
either necrotic tubules or obstructed tubules by casts in each image was quantified as 
reported (Muroya et al. 2015, Pegues et al. 2013). All morphometric analyses were 
performed in a blinded manner. 
The effects of interest were tested using a Student’s paired t-tests, or two-factor 
analysis of variance (ANOVA) with repeated measures when appropriate. Data were 
presented as a mean ± standard error of the mean. The changes were considered to be 
significant if the p-value was less than 0.05. 
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Results 
Plasma creatinine was measured 24 hours and 7 days after cold IRI to evaluate 
kidney injury. At 24 hours after cold IRI, the plasma creatinine had no significant 
increase in mice with 1 and 2 hours cold ischemia, which were 0.15±0.04 and 0.16±0.05 
mg/dl, respectively, compared with sham group (0.09±0.04 mg/dl). The plasma 
creatinine increased to 0.34±0.06 mg/dl in mice with 3 hours cold ischemia (P<0.01 vs. 
Sham group, 1 and 2 hours groups), to 1.14±0.21 mg/dl in mice with 4 hours cold 
ischemia (P<0.01 vs Sham group, 1, 2, and 3 hours groups) and 2.65±0.14 mg/dl in 
mice with 5 hours cold ischemia (P<0.01 vs other 5 groups). At 7 days after cold IRI, the 
plasma creatinine was still significantly higher in mice with 3 and 4 hours cold ischemia 
compared with the other 3 groups (Figure 22A) (P<0.01 vs Sham group, 1 and 2 hours 
groups). The mice with 5 hours cold ischemia all died within 2-3 days after cold IRI. The 
plasma creatinine had no significant difference among sham, 1 and 2 hours groups.  
Plasma KIM-1 and NGAL were measured 24 hours after cold IRI. The plasma 
KIM-1 and NGAL had no significant changes in mice with 1 and 2 hours of cold 
ischemia compared with the sham-operated animals, but significantly and stepwise 
increased in the mice with 3, 4, and 5 hours cold ischemia (Figure 22B and 22C) 
(P<0.05 vs Sham group, 1 and 2 hours groups).  
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Plasma creatinine, KIM-1, and NGAL were measured and compared after cold 
ischemia. A) At 24 hours after cold IRI, the plasma creatinine were highest in the mice 
with 5 hours cold ischemia, followed by the mice with 4 and 3 hours cold ischemia, and 
lowest in the mice with 1 and 2 hours cold ischemia. At 7 days after cold IRI, the plasma 
creatinine was still significantly higher in mice with 3 and 4 hours cold ischemia 
compared with the other 3 groups (n=6/group). *P<0.01 vs Sham group, 1 and 2 hours 
groups; #P <0.05 vs 3 hours group; &P<0.01 vs 4 hours group. B) The plasma KIM-1 
significantly and stepwise increased in the mice with 3, 4, and 5 hours cold ischemia 
compared with the mice with 1 and 2 hours cold ischemia (n=5/group). *P<0.01 vs 
Sham group, 1 and 2 hours groups; #P <0.01 vs 3 hours group; &P<0.05 vs 4 hours 
group. C) The plasma NGAL was also higher in mice with 3, 4 and 5 hours cold 
ischemia compared with the mice with 1 and 2 hours cold ischemia (n=5/group).*P<0.05 
vs Sham group, 1 and 2 hours groups; #P<0.05 vs 3 hours group; &P<0.01 vs 4 hours 
group. 
 
 
 
Figure 22. Renal injury markers after cold IRI. 
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GFR was measured in conscious mice before cold IRI at baseline and 7 days 
after cold IRI. Baseline GFR was similar in all groups of mice. GFR in the sham group 
was decreased by about 30% due to uninephrectomy. At 7 days after cold IRI, the GFR 
had no significant difference in mice with 1 and 2 hours cold ischemia (161.7±12 and 
163.4±8.4µl/min, respectively) compared with the sham group (175.2±15.1 µl/min). The 
GFR decreased by 24.1±5.1% in mice with 3 hours cold ischemia and by 42.0±7.4% in 
mice with 4 hours cold ischemia compared with the sham group (Figure 23) (P<0.05 vs 
Sham group). 
GFR were measured in conscious mice before IRI at baseline as well as 7 days after IRI 
in the mice with cold ischemia. GFR had no significant difference in mice with 1 and 2 
hours cold ischemia compared with the sham group. GFR decreased by 24.1±5.1% in 
mice with 3 hours cold ischemia and by 42.0±7.4% in mice with 4 hours cold ischemia 
compared with the sham group. (n=6/group) *P<0.05 vs Sham group, 1 and 2 hours 
groups; #P<0.05 vs 3 hours group. 
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Figure 23. GFR in conscious mice. 
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Figure 24. Histology (continued on next page). 
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Histology by PAS staining showed slices of the cortex, corticomedullary region (CMR), 
outer medulla (OM) and inner medulla (IM) (A). Kidney injury was quantitatively 
measured by percentage of tubular necrosis (B) and obstructed tubules by casts (C) in 
the cortex, CMR, OM and IM in all cold ischemia groups. (n=4/group) *P<0.01 vs 1 and 
2 hours group; #P<0.05 vs 3 hours group; &P<0.01 vs 4 hours group. Quantitative 
analysis was performed on ten randomly chosen fields in each kidney tissue slice. 
 
A comparison of histologic appearance of PAS-stained kidney sections 24 hours 
after different cold ischemic time length is presented in Figure 24A. The kidneys with no 
more than 2 hours cold ischemia exhibited only moderate tubular injury, such as 
epithelial cell swelling and intratubular debris. As the cold ischemic time prolonged, the 
degree of tubular injury was significantly increased with marked diffusely obstructed 
tubules by casts (especially in OM and IM) and necrotic tubules (particulary in CMR and 
OM). The mice with 5 hours cold ischemia showed the most severe tubular injury with 
the largest incidence of tubular obstruction by casts and tubular necrosis (P<0.05 vs 1, 
2 3 and 4 hours groups), followed by the mice with 4 hours cold ischemia and the mice 
with 3 hours cold ischemia (Figure 24B and 24C) (P<0.05 vs 1 and 2 hours groups). 
Figure 24. Histology. 
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Discussion 
In the present study, we develop and characterize a novel in vivo IRI-induced AKI 
model that is exclusively induced by cold ischemia, which provides a new tool to 
investigate renal IRI in kidney transplantation. 
In this model, the blood in the kidney was first flushed out with cold saline and 
then the kidney was maintained in a kidney cup with circulating cold saline. IRI was 
induced by clamping of the renal pedicle. The body temperature was maintained at 
37°C during the experiment. After releasing the clip on the renal pedicle, the kidney cup 
was removed and the kidney was reperfused by blood at body temperature. This 
approach mimics the cold ischemia and kidney transplantation surgical procedures but 
avoids warm ischemia.  
Although UW solution is the primary choice for cold storage of deceased donor 
kidneys in clinical transplantation (Belzer et al. 1992, Muhlbacher et al. 1999, Southard 
et al. 1990), various kinds of perfusion and preservation solutions, including normal 
saline (Martins 2006, Rong et al. 2012, Tian et al. 2010), phosphate buffered saline 
(Lutz et al. 2007), Ringer’s solution (Wang et al. 2003b) and UW solution (Tse et al. 
2014) are used in mouse kidney transplantation. While the effects of different solutions 
in mouse kidney transplants have not been compared, it has been considered that the 
preservation solutions with sticky properties may result in obstructions of the 
microcirculation in mice (Tse et al. 2014). Hence, we perfused and preserved the kidney 
with cold saline during the ischemic stage in this model, as most recent studies did in 
mouse kidney transplants (Rong et al. 2012, Tian et al. 2010, Tse et al. 2013).  
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The severity of renal injury induced by ischemia is associated with the ischemic 
times (Bonventre & Yang 2011, Munshi et al. 2011, Wei & Dong 2012). As indicated by 
the levels of plasma creatinine, KIM-1, NGAL, and histology, the mice with 5 hours of 
cold renal ischemia induced severe AKI and died with 2-3 days after cold IRI. The mice 
with less than 2 hours of cold ischemia had no significant kidney injury. Thus, in this 
model, the severity of renal injury could be easily controlled by adjusting the duration of 
cold ischemia in the kidney. The plasma creatinine level and GFR at 7 days after 
surgery indicated that the mice made almost a full recovery of renal function from 
moderate AKI induced by less than 3 hours cold ischemia. This is consistent with the 
clinical situation in deceased-donor kidney transplant in which the prolonged cold 
ischemia time is associated with a higher risk of delayed graft function and a lower graft 
survival rate (Kayler et al. 2011, Perez Valdivia et al. 2011, Sert et al. 2014). It has been 
well-documented that the corticomedullary region, comprising the S3 segment of the 
proximal tubule and thick ascending limb, is most susceptible in IRI (Bonventre & Yang 
2011, Devarajan 2006). The histology of this cold renal IRI model showed the same 
pattern that the most severe tubular injury was observed in the CMR with the largest 
percentage of necrotic tubules. However, in this model, the inner medulla exhibited 
diffuse tubular obstruction by casts, which is inconsistent with warm renal IRI models, 
suggesting that the pathophysiological changes and mechanisms of IRI induced by cold 
ischemia might be distinguished from those caused by warm ischemia (Bonventre & 
Yang 2011, Devarajan 2006).    
This innovative in vivo renal ischemia model offers the potential to investigate the 
distinctive pathophysiological changes in cold ischemia reperfusion induced AKI beyond 
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the traditional AKI models induced by warm renal ischemia reperfusion. In addition, by 
using this new model, it becomes possible to investigate the differences and similarities 
in signal pathway and mechanisms of AKI induced by warm or cold ischemia. The 
availability of this model in the mouse further advances the capacity for investigation of 
mechanisms with the utilization of genetically modified mice. Moreover, by changing the 
perfusion and preservation solutions, the effect upon the cold storage of any potential 
therapeutic agent or novel organ preservation solution in kidney transplant can be 
assessed in this model. 
In summary, we developed and characterized a novel in vivo IRI mouse model in 
which the renal IRI is exclusively induced by cold ischemia. The cold ischemia phase in 
this model to a large extent mimics the kidney storage in deceased-donor kidney 
transplants. Therefore with our sophisticated surgical procedure, this new design 
provides an additional tool for investigating the pathophysiological changes and the 
underlying mechanisms in renal IRI induced by cold ischemia, as well as in studying the 
preservation solutions.  
 
 
 
 
 
78 
 
 
 
 
 
 
Chapter Three: Renal Infarction Induced Chronic Kidney Disease 
 
 
Project I: renal infarction and hypertension 
 
Abstract 
Hypertension is frequently observed in patients with renal infarction. The 
pathophysiological mechanism for the development of hypertension in renal infarction 
has not been elucidated. In the present study, we developed an animal model of 
hypertension by ligation of a renal artery branch to induce renal infarction to test our 
hypothesis that partial renal infarction induces hypertension mediated by inflammation. 
The renal artery in C57BL/6 mice typically bifurcates into two branches before 
reaching the renal hilum. We labeled the vascular architecture originated from each 
renal artery branch with lectin with confocal microscope.  
Partial renal infarction was performed by ligating either upper (LU) or lower (LL) 
branch of the left renal artery while the right kidney remained intact. MAP quickly 
increased within 3 days after renal infarction, which was from 95.8±6.1 to 120.4±4.6 
mmHg in UL group and from 97.5±5.6 to 114.3±5.6 mmHg in LL group 4 weeks after 
renal infarction. Plasma renin concentration (PRC) and heart rate (HR) were elevated 
and returned to baseline within 7 days after renal infarction. Inflammatory markers of 
TNFα and IL-6 in infarcted kidney and plasma significantly increased. Moreover, 
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resection of the infarction zone 2 weeks after renal infarction normalized the blood 
pressure and the pro-inflammatory cytokines. 
In conclusion, partial renal infarction with the ligation of a renal artery branche in 
C57BL/6 mice induced hypertension, which was associated with initially elevated renin 
and sympathetic nerve activity and correlated with chronically enhanced inflammatory 
response that is dependent on the infarcted region.  
 
Introduction 
Renal infarction, characterized with an interruption of blood supply to a portion of 
or the whole kidney, could result in irreversible kidney damage and subsequent necrosis 
of renal parenchyma along with a decline in kidney function (Bourgault et al. 2013, 
Eltawansy et al. 2014). The incidence of renal infarction was reported at approximate 
0.003 to 0.007% in previous clinical studies (Domanovits et al. 1999, Huang et al. 2007, 
Korzets et al. 2002, Paris et al. 2006). However, due to a lack of specific clinical 
manifestation, renal infarction is frequently underdiagnosed and its incidence is largely 
underestimated. According to the results of a retrospective postmortem study, 205 renal 
infarction cases were diagnosed in a total of 14411 autopsies, indicating an actual 
incidence could be around 1.4%.  
The epidemiology of renal infarction is complex and has not been completely 
understood. Various risk factors, including arteriosclerosis, atrial fibrillation (Antopolsky 
et al. 2012a, Frost et al. 2001, Saeed 2012), hypercoagulation (Antopolsky et al. 2012a, 
Saeed 2012) and endocarditis (Antopolsky et al. 2012a, Lumerman et al. 1999, Wong et 
al. 1984) are involved with renal infarction. Renal thromboembolism originated from the 
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heart or aorta is recognized as the primary cause of renal infarction (Eltawansy et al. 
2014, Korzets et al. 2002, Saeed 2012).  Despite of a few case reports with normal 
blood pressure (Alamir et al. 1997, Javaid et al. 2009), hypertension is commonly 
observed in renal infarction. Based on the outcomes of a retrospective cohort study, 
hypertension was identified in 48% of the renal infarction patients (Bourgault et al. 
2013). Another retrospective clinical study also indicated that renal infarction resulted in 
acute or aggravated hypertension in previous normotensive or hypertensive patients. 
The renal infarction-induced hypertension was usually ameliorated following surgery or 
renal artery angioplasty (Paris et al. 2006).  
However, the pathophysiological changes in renal infarction and the mechanisms 
of renal infarction induced hypertension have not been fully understood. In addition, 
mouse models of partial renal infarction are lacking. Therefore, in present study, we 
created a partial renal infarction model in C57BL/6 mice by ligating either the upper or 
lower branch of the renal artery in the left kidney while the right kidney remained intact 
to determine whether partial renal infarction induces hypertension and investigate the 
potential underlying mechanisms.  
 
Methods 
Dylight 488 and Dylight 594 labeled tomato lectin (DL-1174 and DL-1177; Vector 
Laboratories, CA, USA) were used to mark vasculature from two branches of the renal 
artery. The mice were anesthetized with pentobarbital (50 mg/mL, IP). The left kidney, 
aorta and inferior vena were exposed after making an abdominal incision. Two 
branches of the left renal artery were carefully separated from the left renal vein. The 
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following steps were performed to mark vasculature: 1) the vena cava and the aorta 
below the left renal artery were clamped by one microvascular mini clip (FE690K; 
AESCULAP INC, PA, USA), and then the aorta above the left renal arteries was 
clamped by another clip; 2) an opening was cut on the left renal vein, and the blood was 
flushed out from the left kidney by injecting 1-1.5 mL 0.9% saline through the aorta; 3) 
the upper branch of the renal artery was clamped, 1 mL Dylight 488 labeled tomato 
lectin solution was injected to the kidney through the aorta; 4) 1 mL 0.9% saline was 
injected to the kidney again to flush out Dylight 488 labeled tomato lectin solution; 5) the 
lower branch of the renal artery was clamped after removing the clip on the upper 
branch, 1 mL Dylight 594 labeled tomato lectin solution was then injected to the kidney 
through the aorta; 6) clip on the lower branch was removed and 1-1.5 mL 10% buffered 
formalin (Sigma, MO, USA) was injected to the kidney through the aorta to fix the 
kidney. The left kidney was removed immediately from the mouse and fixed in 10% 
buffered formalin. 100um kidney slices were then sectioned with vibratome (HM 650V; 
Thermo Fisher SCIENTIFIC, MA, USA). Fixed kidney were examined and the 3D 
reconstruction of the kidney were got under a multiphoton laser scanning microscope 
(FV1000 MPE; Olympus Corporation, Tokyo, Japan).   
MAP and HR were continuously measured with a telemetry system in conscious 
mice as described previously (Song et al. 2015, Zhang et al. 2014). Mice were 
anesthetized with inhaled isoflurane. The left carotid artery was exposed by a small 
incision in the middle of the neck. The pressure catheter was implanted in the left 
carotid artery and the telemetric device was placed subcutaneously in the right ventral 
flank of the mice. MAP and HR were measured and recorded for 10 seconds every 2 
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min for 4 hours from 1:00 PM to 5:00 PM starting from 7 days after the transmitter 
implantation.  
The mice were divided into four groups: 1) upper branch ligation group (UL); 2) 
lower branch ligation group (LL); 3) upper renal resection group (UL+R); and 4) lower 
renal resection group (LL+R). Basal MAP and HR were recorded for three days, partial 
renal infarction was then performed in UL and LL groups by ligating either upper or 
lower branch of renal artery in the left kidney while the right kidney remained intact. 
Briefly, the mice were anesthetized with pentobarbital (50 mg/mL, IP). A midline 
abdominal incision was performed to expose the left kidney. The two branches of renal 
artery in the left kidney were carefully separated from the renal vein (Figure 24). Either 
upper or lower branch of renal artery (Figure 25) was ligated using a 7–0 braided silk 
suture (07C1500160; Teleflex Medical OEM, IL, USA). The wound was sutured and the 
mouse was kept in the recovery cage for 24 hours. In UL+R and LL+R groups, partial 
renal infarction was performed as described before and the infarction zone was 
resected 14 days after inducing renal infarction. MAP and HR were measured and 
recorded for 4 weeks in all groups. Four weeks after inducing partial renal infarction, all 
animals were anesthetized again with inhaled isoflurane. Left kidneys were harvest for 
inflammatory factors levels measurement and histology. 
We collected about 20 µL blood sample from the tail vein in 50 µL heparinized 
micro-hematocrit capillary tube (22-362-566; Fisher, NH, USA) 24 hours and once a 
week after inducing renal infarction. Plasma was got by 5 minutes centrifugation (8000 
rpm, 4˚C). All of plasma samples were stored at -80°C before renin assay. PRC was 
measured by using angiotensin I (Ang I) enzyme immunoassay (EIA) kit as we reported 
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previously (S-1188; Bachem, CA, USA). Briefly, two microliter plasma sample was thaw 
at room temperature and added into 28 µL EIA buffer to make 15 fold dilution. The 
diluted plasma (10 µL) was incubated for 20 min with 0.4 μmol/L porcine 
angiotensinogen (AGT) (SCP0021; Sigma, MO, USA), 50 mmol/L sodium acetate (pH 
6.5), 2 mmol/L AEBSF (A8456; Sigma, MO, USA), 5 mmol/L EDTA (pH 8) and 1 mmol/L 
8-hydoxoyquinoline (252565; Sigma, MO, USA) in an Eppendorf tube. The total volume 
of this master mix was 50 µL. The amount of Ang I was measured using an EIA kit. PRC 
was expressed as the amount of Ang I generated per hour per microliter of plasma. 
Representative image for two branches of renal artery. 
  
Total RNAs were extracted from the left kidney. The RNAs were digested with 
RNase-free DNase (Promega, WI, USA) to avoid the genomic contamination. Reverse 
transcription was performed to synthesize cDNA templates. The primers set for TNFα, 
IL-6 and β-actin genes were designed using Prime3Plus (TNFα- F: 5’- 
ATGAGAAGTTCCCAAATGGC-3’, TNFα-R: 5’- CTCCACTTGGTGGTTTGCTA-3’; IL-6-
F: 5’-CTCTGGGAAATCGTGGAAAT-3’, IL-6-R: 5’- CCAGTTTGGTAGCATCCATC-3’; 
and β-actin-F: 5’-GTCCCTCACCCTCCCAAAAG-3’, β-actin-R: 5’-
GCTGCCTCAACACCTC-AACCC-3’). Real-time PCR analysis was performed using iQ 
 
 
 
 
 
   
Figure 25. Images for renal artery. 
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SYBR Green Supermix (Bio-Rad, CA, USA) and CFX96 Real-Time Detection System 
(Bio-Rad, CA, USA) according to the manufacturer's protocol. The comparative Ct 
method (2–ΔΔCt) was used to analyze data and calculate the relative mRNA expression 
level after PCR program. 
The plasma levels of IL-6 and TNF-α were measured by using enzyme linked 
immunosorbent assay (ELISA) kit (Abcam, Cambridge, MA). ELISA were performed as 
described in the manufacturers.  
The kidneys were harvested at 4 weeks after inducing renal infarction and fixed 
in 4% paraformaldehyde solution for 24 hours. The kidney tissue was embedded in 
paraffin and 2 µm kidney tissue slices were cut and stained with Masson trichrome at 
USF health diagnostic laboratory (Sugimoto et al. 2007, Zeisberg et al. 2003). The renal 
injury was evaluated by morphometric analysis of interstitial fibrosis and tubular crysts. 
 
Results 
To characterize the vascular architecture originated from two renal artery 
branches, tomato lectin with different conjugated fluorophores was perfused via each 
branch respectively. The fluorescence images of the whole kidney slice showed a clear 
border between green and red fluorescence signals. The approximate 2/3 upper portion 
of the kidney slice only displayed the green florescence while red fluorescence signal 
exclusively existed in the lower part (Figure 26A). The fluorescence images with higher 
magnification showed the detailed vascular architecture in the border zone. Some 
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peritubular capillaries exhibited both green and red florescence, however, no glomeruli 
showed both green and red fluorescence (Figure 26B and Figure 26C). 
Figure 26. Vascular architecture of the kidney (continued on next page). 
 
Figure 26. Vascular architecture of the kidney (continued on next page). 
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Figure 26. Vascular architecture of the kidney (continued on next page). 
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The fluorescence images of the whole kidney slice showed a clear border between 
green and red signals (A). In the border zone, either red or green fluorescence signal 
displayed alone in each specific glomerulus (B and C). Blue signal: DAPI; Red signal: 
Dylight 594 labeled tomato lectin; Green signal: Dylight 488 labeled tomato lectin.  
 
Figure 26. Vascular architecture of the kidney. 
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To determine whether partial renal infarction alters blood pressure, we measured 
MAP with the telemetry system in the mice after inducing renal infarction. Baseline MAP 
was similar in UL, LL and sham groups. MAP increased by 42.9±3.7 % (from 95.8±6.1 
to 136.9±6.2 mmHg) in UL group and by 35.6±4.3 % (from 97.5±5.6 to132.3±3.1 
mmHg) in LL group in 2 to 3 days after inducing renal infarction and gradually declined 
until 6 to 7 days after inducing renal infarction. Four weeks after inducing renal 
infarction, MAP increased by 23.8±2.5% to 120.4±4.6 mmHg in UL group (p<0.01 vs 
baseline) and by 19.0±1.1% to 114.3±5.6 mmHg in LL group (p<0.01 vs baseline) 
compared with baseline (Figure 27A). In sham group, MAP was constant during the 
experiment. 
To determine whether the infarction zone has any effect on the blood pressure, 
we removed the infarction zone 14 days after inducing renal infarction. MAP in UL+R 
and LL+R groups followed the same trend as that in UL and LL groups before removing 
the infarction zone. MAP raised by 23.8±2.6% in UL+R group and by 24.1±1.9% in 
LL+R group. However, the MAP slowly returned to baseline both in UL+R and LL+R 
groups in 5 to 7 days after removing the infarction zone (Figure 27B).  
To determine whether renal infarction has any effect on sympathetic nerve 
activity, HR were recorded with the telemetry system. Baseline heart rate in UL group 
(526±15 bpm) was similar to that in LL group (538±14 bpm). The HR increased to 
732±21 bpm in UL group and 687±17 bpm in LL group in 2 to 3 days after inducing 
renal infarction (p<0.01 vs baseline, Figure 28). The HR gradually returned to the basal 
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value in 5 to 6 days after inducing renal infarction. HR in sham group was stable during 
experiment. 
MAP were measured in all of groups. A) The change of MAP after inducing renal 
infarction in UL and LL groups. (n=8) *p< 0.01 vs baseline, #p< 0.01 vs sham. B) The 
change of MAP after inducing renal infarction and resecting infarction zone in UL+R and 
LL+R groups. (n=5) *p< 0.01 vs baseline. UL: upper branch ligation; LL: lower branch 
ligation; UL+R: upper branch resection; LL+R: lower branch resection.  
Figure 27. MAP after inducing renal infarction. 
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The HR increased to the peak in 2 to 3 days after inducing renal infarction and gradually 
returned to the basal value in 5 to 6 days after inducing renal infarction in UL and LL 
groups. HR in sham group was stable after surgery and had no difference with baseline. 
(n=8) *p< 0.01 vs baseline. UL: upper branch ligation; LL: lower branch ligation. 
In UL and LL groups, the PRC increased about five folds 24 hours after inducing renal 
infarction compared with baseline and returned to basal value in 1 week after inducing 
renal infarction. (n=7) *p< 0.01 vs baseline. UL: upper branch ligation; LL: lower branch 
ligation. 
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Figure 28. HR after inducing renal infarction. 
Figure 29. PRC after inducing renal infarction. 
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To determine whether PRC has any effect on the increase of blood pressure, we 
measured PRC after inducing renal infarction in UL and LL groups. PRC increased 
about five fold 24 hours after inducing renal infarction both in UL and LL groups 
compared with baseline (p<0.01 vs baseline,  Figure 29). PRC returned to basal value 
in 1 week after inducing renal infarction. 
To determine whether renal infarction induces inflammation, we measured 
mRNA and protein levels of TNFα and IL-6 in left kidney homogeneous at 4 weeks after 
inducing renal infarction. In UL and LL groups, TNFα mRNA level increased about 4 
folds (p<0.01 vs. sham) compared with sham group (Figure 30A). IL-6 mRNA level also 
increased about 3 folds (p<0.01 vs. sham) compared with sham group (Figure 30B). In 
UL+R and LL+R groups, TNFα and IL-6 mRNA levels had no significant increase 
compared with sham group. 
Plasma TNFα and IL-6 levels were measured after inducing renal infarction. 
Baseline plasma TNFα was similar in all groups. Plasma TNFα was about 9 folds higher 
in UL, LL, UL+R and LL+R groups (p<0.01 vs. sham) compared with sham group at 24 
h after inducing renal infarction, and still 5 folds higher (p<0.01 vs. sham) at 14 days 
after inducing renal infarction. At 28 days after inducing renal infarction, plasma TNFα 
was 60.69±16.25 pg/ml in UL group and 82.62±19.40 pg/ml in LL group (p<0.01 vs. 
sham), which was significant higher than sham group (9.51±4.47 pg/ml), but it had no 
significant increase in UL+R and LL+R groups (Figure 31A). The difference of plasma 
IL-6 in all groups was the same as plasma TNFα at 24 h and 14 days after inducing 
renal infarction. At 28 days after inducing renal infarction, plasma IL-6 was also 
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significant higher in UL and LL groups (96.71±14.07 and 71.79±17.43 pg/ml) compared 
with sham group (p<0.01 vs. sham), but it had no significant change in UL+R and LL+R 
groups (Figure 31B). 
The mRNA levels of TNFα and IL-6 in left kidney homogeneous were measured and 
compared among UL, LL, UL+R, LL+R and sham groups 4 weeks after inducing renal 
infarction. A) TNFα mRNA level increased about 4 folds both in UL and LL groups 
compared with sham group. (n=5) *p<0.01 vs sham.  B) IL-6 mRNA level increased 
about 3 folds both in UL and LL groups compared with sham group. (n=5) *p<0.05 vs 
sham. UL: upper branch ligation; LL: lower branch ligation; UL+R: upper branch 
resection; LL+R: lower branch resection. 
 
Figure 30. Inflammatory factors mRNA level. 
93 
 
 
 
Plasma TNFα (A) and IL-6 levels (B) were measured and compared among sham, UL, 
UL+R, LL and LL+R groups after inducing renal infarction. At 28 days after inducing 
renal infarction, plasma TNFα and IL-6 was significant higher than sham group, but it 
had no significant increase in UL+R and LL+R groups (n=7) *p<0.01 vs sham. UL: 
upper branch ligation; LL: lower branch ligation; UL+R: upper branch resection; LL+R: 
lower branch resection. 
 
Figure 31. Plasma inflammatory factors. 
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Kidney weight were measured at 4 weeks after inducing renal infarction. The 
right kidney weight had no significant difference among all groups. However, the left 
kidney weight were lower in UL and LL groups than sham group (p<0.05 vs. sham). The 
left kidney weight in UL+R and LL+R groups were also lower than sham group (p<0.01 
vs. sham), but had no significant difference compared with UL and LL groups (Figure 
32A and 32B). 
Kidney images (A) and kidney weight (B) at 28 days after inducing renal infarction. (UL 
and LL groups: n=8; UL+R and LL+R groups: n=5) *p<0.05 vs sham. UL: upper branch 
ligation; LL: lower branch ligation; UL+R: upper branch resection; LL+R: lower branch 
resection. 
 
 
Figure 32. Kidney weight. 
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At 4 weeks after inducing renal infarction, interstitial fibrosis was observed by 
collagen accumulation in widened interstitial space and the tubular cysts was observed 
by enlargement of tubular lumen (Figure 33). 
At 28 days after inducing renal infarction, interstitial fibrosis was observed by collagen 
accumulation in widened interstitial space (yellow triangle) and the tubular cysts was 
observed by enlargement of tubular lumen (black triangle). 
 
                                                                                   
 
 
Figure 33. Histology. 
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Discussion 
In the present study, we developed a partial renal infarction model in C57BL/6 
mouse by ligating one of the two renal artery branches in the left kidney with an intact 
contralateral kidney.  MAP significantly raised in mice with either branch ligation. PRC 
and HR were increased. Inflammatory response was enhanced. Resection of the 
infarction zone normalized blood pressure. 
In human, the renal artery is typically divided into five segmental arteries near the 
renal hilum with one posterior and four anterior (el-Galley & Keane 2000, Urban et al. 
2001). Accessory renal artery is a common vascular variant in human and exists in 
approximately one-third of the population (Spring et al. 1979, Urban et al. 2001). 
Moreover, the anatomy of renal artery and even its branching have been well 
characterized in various kinds of laboratory animals, like dog (Marques-Sampaio et al. 
2007), pig (Evan et al. 1996, Sampaio et al. 1998), rabbit and rat (Fuller & Huelke 1973, 
Yoldas & Dayan 2014). However, the morphology of the renal artery in mouse, in 
particularly, the most used laboratory rodent C57BL/6 mouse was not documented 
before. On the basis of our observation in current study, accessory renal artery is rare in 
C57BL/6 mouse; the left renal artery is bifurcate into two branches at approximate 5 to 
10 mm before entering parenchyma; the diameter of upper branch is generally about 
twice of the lower, suggesting the renal blood supply via the upper branch is larger than 
that through the lower. Accordingly, ligation of upper branch causes ischemia of nearly 
2/3 kidney in the upper portion, while occlusion of the lower branch results in 
approximate 1/3 renal parenchymal ischemia in the lower part of the kidney. Moreover, 
as the branching site of either adrenal artery or ureteral artery from the stem of renal 
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artery is prior to the bifurcation point of the renal artery branches, ligation in either 
branch of renal artery would not effect on the blood supply to the adrenal grand or 
ureter. 
To characterize the vascular architecture originated from the two renal artery 
branches, tomato lectin with different conjugated fluorophores was perfused via either 
upper or lower branch respectively to distinguish the vasculature from each other. 
Tomato lectin, a kind of subunit glycoprotein from Lycopersicon esculentum is utilized in 
the visualization of vasculature on account of its capacity of binding to glycocalyx of 
vascular endothelium. The fluorescence images of the whole kidney slice showed a 
clear border between green and red signals which indicated that the vasculature 
distributed in the upper portion of renal parenchyma had its origin from the upper renal 
artery branch; on the contrary, the rest renal vasculature existed in the lower part of the 
kidney was originated solely from the other renal artery branch. In the border zone, 
even though some peritubular capillaries exhibited both green and red color, for each 
specific glomerulus, either red or green fluorescence signal displayed only, indicating no 
overlapping in blood supply for glomeruli between the two branches.   
To determine the changes in blood pressure after partial renal infarction, we 
measured the MAP with the telemetry system. Blood pressure raised rapidly and 
peaked at 2 to 3 days after surgery, then gradually declined but kept at an elevated 
level throughout the remainder experiment course. Even though the upper renal artery 
branch supplies more blood flow to a larger portion of the renal parenchyma compared 
with the lower branch, there is no significant difference in MAP between the renal 
infarction models with the ligation in either upper or lower branch. While no studies in 
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mouse models, Griffin et al. reported that renal mass reduction in Sprague-Dawley rats 
by unilateral ligation in one or two of the three renal artery branches plus 
uninephrectomy of contralateral kidney resulted in a significant increase in systolic 
blood pressure with the peak at 3 to 5 days after surgery (Griffin et al. 1994). In addition, 
previous studies by Fekete et al. (Fekete et al. 1975) and Tarjan et al. (Tarjan & Fekete 
1975)  demonstrated that unilateral total kidney ligation in rats induced hypertension. 
Inflammation has been demonstrated to play an essential role in the 
development of hypertension (Das 2006, Guzik et al. 2007, Majid et al. 2015). Patients 
with renal infarction exhibit enhanced inflammatory response (Antopolsky et al. 2012a, 
Bourgault et al. 2013, Korzets et al. 2002). Hence, in regard to the underlying 
mechanisms contributing to the blood pressure outcomes after renal infarction in the 
present study, we examined the level of pro-inflammatory cytokines, TNF-α and IL-6, in 
both partially infarcted kidney and plasma. We found that renal infarction not only 
resulted in local inflammation but also lead to upgraded systemic inflammatory status. 
Furthermore, resection of the infarction zone normalized the blood pressure and 
significantly reduced the pro-inflammatory cytokines level. These results consist with the 
clinical outcomes of renal infarction patients that nephrectomy of the infarction zone 
ameliorated hypertension (Paris et al. 2006). In addition, our finding is also consistent 
with the previous studies on renal mass reduction, in which compared with the approach 
with excision of both kidney poles, the reduction of renal parenchyma mass in Sprague-
Dawley rats by ligating two of the three artery branches induced higher blood pressure 
with an enhanced renal inflammation (Griffin et al. 1994, Yang et al. 2010). 
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Besides inflammation, renal infarction induced hypertension in clinical patients is 
also associated upregulated renin angiotensin system (Candel-Pau et al. 2008, Paris et 
al. 2006). Similarly, current study also demonstrated that ligation in renal artery branch 
initially induced upregulation in plasma renin. However, it returned to normal within a 
week and stayed at a normal level, but the blood pressure maintained at the similar high 
level. Renin is generated and released from granular cells in JGA and its secretion is 
controlled by renal baroreceptor, sodium chloride delivery at macula densa and 
sympathetic nervous system (Kurtz 2011, Peti-Peterdi & Harris 2010, Vander 1967). 
The fluorescence images of intrarenal vascular architecture indicated that the blood 
supply of each specific glomerulus was solely from only one of the two renal artery 
branches without any overlapping. Thus, ligation of either branch of renal artery would 
not induce partial ischemia in JGAs, which could promote renin release like in 2K1C 
model. Therefore, the increased level of plasma renin might be partially released from 
the JGAs in the infarction area before they turn to ischemic necrosis. On the other hand, 
the heart rate, which represents the intensity of sympathetic nerve activity (Petretta et 
al. 1997, Robinson et al. 1966), was significantly increased after renal infarction and 
gradually decline to basaline along with the change in plasma renin. These results 
indicate that the enhanced sympathetic activity may contribute to the increased plasma 
renin concentration.  
In summary, we characterized the intrarenal vascular architecture originated from 
each renal artery branch in mouse kidney. Ligation in one of the renal artery branches in 
C57BL/6 mice induced hypertension, which was associated with the initially upregulated 
sympathetic nerve activity and increased plasma renin concentration and correlated 
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with chronically enhanced inflammatory response. Furthermore, in renal infarction 
induced hypertensive mice, resection of the infarction zone normalized hypertension 
along with a downregulation of pro-inflammatory cytokines. We conclude that renal 
infarction induces hypertension mediated by enhanced inflammatory response 
dependent on the infarcted tissue. 
 
Project II: renal infarction and chronic kidney disease  
 
Introduction 
CKD is characterized by a progressive loss in kidney function and could 
eventually develop into ESRD. CKD is a major health issue in the United States with 
increasing morbidity and significant costs. Based on the National Kidney Foundation 
Kidney Disease Outcome Quality Initiative clinical practice guidelines for CKD, the 
prevalence of CKD in the U.S. is approximate 13.1% and the estimated population of 
ESRD is over 0.7 million by 2015 (Coresh et al. 2007, Gilbertson et al. 2005). The risk 
factors for CKD are diverse and the epidemiology is usually multiplicate. Currently, 
diabetes mellitus and high blood pressure have been recognized as the two primary 
causes of CKD (Islam et al. 2009, Levey et al. 2010). Despite of extensive investigation, 
the pathophysiological mechanisms of CKD have not been completed elucidated. A 
better understanding of CKD might provide potential therapeutic targets and advance 
the clinical strategies to prevent or attenuate its progression. 
Various animal models have been developed to study CKD. Five-sixths renal 
mass reduction, produced by uninephrectomy combined with 2/3 parenchyma reduction 
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on the contralateral kidney, is a broadly used model to mimics the CKD secondary to 
reduced nephron number (Purkerson et al. 1976, Shimamura & Morrison 1975, Yang et 
al. 2010). Whereas, the development of CKD following 5/6 nephrectomy, achieved by 
uninephrectomy and surgical excision of 2/3 contralateral kidney, is highly strain-
dependent in mice. C57BL/6 mouse, the most commonly used strain, is relatively 
resistant to 5/6 nephrectomy induced CKD (Leelahavanichkul et al. 2010). On the other 
hand, compared with 2/3 renal mass reduction through surgical excision of kidney 
poles, the approach via ligation in two of the three renal artery branches resulted in 
higher blood pressure and more severe renal injury in 5/6 renal mass reduction models 
of rats (Griffin et al. 1994). However, a combination of uninephrectomy and renal artery 
branch ligation on contralateral kidney to achieve the total 5/6 renal mass reduction has 
nerve been reported before in mice because of the technical difficulty in isolation of 
renal artery branches. Thus, in the present study, we aimed to develop a 5/6 renal mass 
reduction model by uninephrectomy combined with a ligation of upper renal artery 
branch on the contralateral kidney in C57BL/6 mouse and determine whether this model 
is able to increase blood pressure and promote the progression of CKD in C57BL/6 
mouse (Kren & Hostetter 1999). 
 
Methods 
Dylight 488 and Dylight 594 labeled tomato lectin (DL-1174 and DL-1177; Vector 
Laboratories, CA, USA) were used to mark vasculature from two branches of the renal 
artery. The mice were anesthetized with pentobarbital (50 mg/mL, IP). The left kidney, 
aorta and inferior vena were exposed after making an abdominal incision. Two 
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branches of the left renal artery were carefully separated from the left renal vein. The 
following steps were performed to mark vasculature: 1) the vena cava and the aorta 
below the left renal artery were clamped by one microvascular mini clip (FE690K; 
AESCULAP INC, PA, USA), and then the aorta above the left renal arteries was 
clamped by another clip; 2) an opening was cut on the left renal vein, and the blood was 
flushed out from the left kidney by injecting 1-1.5 mL 0.9% saline through the aorta; 3) 
the upper branch of the renal artery was clamped, 1 mL Dylight 488 labeled tomato 
lectin solution was injected to the kidney through the aorta; 4) 1 mL 0.9% saline was 
injected to the kidney again to flush out Dylight 488 labeled tomato lectin solution; 5) the 
lower branch of the renal artery was clamped after removing the clip on the upper 
branch, 1 mL Dylight 594 labeled tomato lectin solution was then injected to the kidney 
through the aorta; 6) clip on the lower branch was removed and 1-1.5 mL 10% buffered 
formalin (Sigma, MO, USA) was injected to the kidney through the aorta to fix the 
kidney. The left kidney was removed immediately from the mouse and fixed in 10% 
buffered formalin. 100 µm kidney slices were then sectioned with vibratome (HM 650V; 
Thermo Fisher SCIENTIFIC, MA, USA). Fixed kidney were examined and the 3D 
reconstruction of the kidney were got under a multiphoton laser scanning microscope 
(FV1000 MPE; Olympus Corporation, Tokyo, Japan).   
The mice were anesthetized again with isoflurane 24 hours after renal ischemia. 
The blood samples (100 µl) were collected through the retro-orbital venous sinus and 
centrifuged at 8000 rpm for 5 minutes at 4˚C. The plasma (50 µl/each) was obtained for 
creatinine, KIM-1 and NGAL measurements. Creatinine concentration was measured by 
HPLC at the O’Brien Center Core of the University of Alabama at Birmingham.   
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MAP were continuously measured with a telemetry system in conscious mice as 
described previously (Song et al. 2015, Zhang et al. 2014). Mice were anesthetized with 
inhaled isoflurane. The left carotid artery was exposed by a small incision in the middle 
of the neck. The pressure catheter was implanted in the left carotid artery and the 
telemetric device was placed subcutaneously in the right ventral flank of the mice. MAP 
were measured and recorded every 1 min for 2 hours from 2:00 PM to 4:00 PM 
beginning 7 days after the catheter implantation.  
The mice were divided into upper branch ligation group (UX+Ligation) and upper 
renal resection group (UX+Resection). In UX+Ligation group, partial renal infarction was 
performed by ligating upper branch of renal artery in the left kidney while removing the 
right kidney. Briefly, the mice were anesthetized with pentobarbital (50 mg/mL, IP) and a 
midline abdominal incision was made to expose two kidneys. After removing the right 
kidney, the two branches of renal artery in the left kidney were exposed and upper 
branch of renal artery was ligated using a 7–0 braided silk suture (07C1500160; 
Teleflex Medical OEM, IL, USA). The wound was sutured and the mouse was kept in 
the recovery cage for 24 hours. In UX+Resection group, the ligation zone was resected 
right after ligating upper branch. MAP were measured and recorded for 3 months in all 
groups. The mice in UX group underwent uninephrectomy of right kidney without 
ligation or resection of left kidney. At the end of experiments, all of mice were 
anesthetized again with inhaled isoflurane and left kidneys were harvest for 
inflammatory factors levels measurement and kidney injury evaluation. 
The mice were anesthetized every two weeks with isoflurane 24 hours after 
surgery. The blood samples (40 µl) were collected through the retro-orbital venous sinus 
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and centrifuged at 8000 rpm for 5 minutes at 4˚C. The plasma (25 µl/each) was 
obtained for creatinine measurement. Creatinine concentration was measured by HPLC 
at the O’Brien Center Core of the University of Alabama at Birmingham.  
GFR was measured by the plasma FITC-sinistrin clearance with a single bolus 
injection in conscious mice every two weeks after surgery as we previous described 
with modifications (Schreiber et al. 2012, Wang et al. 2016). Briefly, mice were injected 
with FITC-sinistrin solution (5.6 mg/100 g BW) through the retro-orbital venous sinus. 
Blood (<10 µl ) was collected into heparinized capillary tubes through the tail vein at 3, 
7, 10, 15, 35, 55, and 75 minutes after sinistrin injection. The blood samples were 
centrifuged at 8000 rpm for 5 minutes at 4˚C. Plasma (1 µl) was collected from each 
sample. FITC-sinistrin concentration of the plasma was measured using a plate reader 
(Cytation3; BioTek, VT, USA) with 485-nm excitation and 538-nm emission. GFR was 
calculated with a GraphPad Prism 6 (GraphPad Software). 
Mice were placed in metabolic cages 24 h to collect urine every month after 
surgery. To calculate urine ACR, urine albumin concentration was measured by using 
mouse albumin ELISA kit (ab108792; Abcam, Cambridge, MA) and urine creatinine 
concentration was measured by HPLC at the O’Brien Center Core of the University of 
Alabama at Birmingham.  
We collected about 20 µL blood sample from the tail vein in 50 µL heparinized 
micro-hematocrit capillary tube (22-362-566; Fisher, NH, USA) 24 hours and once a 
week after inducing renal infarction. Plasma was got by 5 minutes centrifugation (8000 
rpm, 4˚C). All of plasma samples were stored at -80°C before renin assay. PRC was 
measured by using angiotensin I (Ang I) enzyme immunoassay (EIA) kit as we reported 
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previously (S-1188; Bachem, CA, USA). Briefly, two microliter plasma sample was thaw 
at room temperature and added into 28 µL EIA buffer to make 15 fold dilution. The 
diluted plasma (10 µL) was incubated for 20 min with 0.4 μmol/L porcine 
angiotensinogen (AGT) (SCP0021; Sigma, MO, USA), 50 mmol/L sodium acetate (pH 
6.5), 2 mmol/L AEBSF (A8456; Sigma, MO, USA), 5 mmol/L EDTA (pH 8) and 1 mmol/L 
8-hydoxoyquinoline (252565; Sigma, MO, USA) in an Eppendorf tube. The total volume 
of this master mix was 50 µL. The amount of Ang I was measured using an EIA kit. PRC 
was expressed as the amount of Ang I generated per hour per microliter of plasma. 
Total RNAs were extracted from the left and right kidneys, respectively. The 
RNAs were digested with RNase-free DNase (Promega, WI, USA) to avoid the genomic 
contamination. Reverse transcription was performed to synthesize cDNA templates. 
The primers set for TNFα, IL-6 and β-actin genes were designed using Prime3Plus 
(TNFα- F: 5’- ATGAGAAGTTCCCAAATGGC-3’, TNFα-R: 5’- 
CTCCACTTGGTGGTTTGCTA-3’; IL-6-F: 5’-CTCTGGGAAATCGTGGAAAT-3’, IL-6-R: 
5’- CCAGTTTGGTAGCATCCATC-3’; and β-actin-F: 5’-GTCCCTCACCCTCCCAAAAG-
3’, β-actin-R: 5’-GCTGCCTCAACACCTC-AACCC-3’). Real-time PCR analysis was 
performed using iQ SYBR Green Supermix (Bio-Rad, CA, USA) and CFX96 Real-Time 
Detection System (Bio-Rad, CA, USA) according to the manufacturer's protocol. The 
comparative Ct method (2–ΔΔCt) was used to analyze data and calculate the relative 
mRNA expression level after PCR program. 
The kidneys were harvested and fixed in 4% paraformaldehyde solution 12 
weeks after ligation. Fixed kidney tissues were embedded in paraffin, and 2 µm kidney 
tissue slices were cut and stained with PAS. Ten randomly chosen fields were captured 
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under 400x magnification and the degree of glomerular injury was quantified from the 
percentage of mesangial expansion as reported (Tervaert et al. 2010). 
The kidneys were harvested to evaluate kidney injury under transmission 
electron microscope 3 months after surgery. Briefly, with an incision to the right atrium 
of the heart, 1M phosphate buffered saline (PBS) solution with 0.8 Units/ml heparin was 
perfused via the left ventricle to flush the blood as previously described (3). Small tissue 
pieces (approximately 1 mm3) of renal cortex were cut and fixed in 2% glutaraldehyde 
in 0.1 M sodium cacodylate buffer (pH 7.4) overnight at room temperature. The tissue 
pieces were rinsed with 0.1 M sodium cacodylate buffer (pH 7.4) and treated with 1% 
osmium tetroxide for 2 h. Then the tissue pieces were dehydrated with a series of 
graded ethanol, sequentially infiltrated with 2:1, 1:1, 1:2 mixtures of acetone and resin, 
and embedded in 100% resin. Thin sections (approximately 90-100 nm) were cut and 
examined with transmission electron microscope (JEM-1400Plus) at USF Health Lisa 
Muma Weitz Laboratory. The thickness of glomerular basement membrane (GBM) was 
defined by the shortest distance between endothelial plasma membrane and podocyte 
foot processes. The mean GBM thickness of each glomerulus was calculated as 
described previously. The podocyte foot process was detected and the average width of 
foot process in each glomerulus was determined as described previously. 
 
Results 
To characterize the vascular architecture originated from two renal artery 
branches, tomato lectin with different conjugated fluorophores was perfused via each 
branch respectively. The fluorescence images of the whole kidney slice showed a clear 
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border between green and red fluorescence signals. The approximate 2/3 upper portion 
of the kidney slice only displayed the green florescence while red fluorescence signal 
exclusively existed in the lower part (Figure 34A). The fluorescence images with higher 
magnification showed the detailed vascular architecture in the border zone. Some 
peritubular capillaries exhibited both green and red florescence, however, no glomeruli 
showed both green and red fluorescence (Figure 34B).  
Kidney function of these mice was evaluated by measuring plasma creatinine 
concentration and GFR after surgery. The plasma creatinine increased from 0.11±0.02 
mg/dl to 0.21±0.03 mg/dl in UX+Ligation group and from 0.12±0.03 mg/dl to 0.18±0.02 
mg/dl in UX+Resection group two weeks after surgery, but did not change in UX group. 
The plasma creatinine further increased to 0.31±0.05 mg/dl in UX+Ligation group in 12 
weeks after surgery (p<0.05 vs. baseline), but remained stable in UX+Resection group 
(Figure 35A). Baseline GFR was similar in all groups of mice. GFR in UX group was 
decreased by about 30% due to uninephrectomy. GFR decreased by 50.3±2.2% from 
249.5±12.7 to 118.4±11.9 µl/min in UX+Ligation group and 41.5±4.4% from 221.5±9.1 
to 129.5±15.6 µl/min in UX+Resection group two weeks after surgery. Twelve weeks 
after surgery, the GFR further decreased to 82.9±19.2 µl/min in UX+Ligation group 
(p<0.01 vs. baseline), but had no decrease in UX+Resection group (Figure 35B). 
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Figure 34. Vascular architecture of the kidney (continued on next page). 
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The fluorescence images of the whole kidney slice showed a clear border between 
green and red signals (A). In the border zone, either red or green fluorescence signal 
displayed alone in each specific glomerulus (B). Blue signal: DAPI; Red signal: Dylight 
594 labeled tomato lectin; Green signal: Dylight 488 labeled tomato lectin.  
 
 
 
 
Figure 34. Vascular architecture of the kidney. 
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We measured MAP with the telemetry system in the mice after surgery. Baseline 
MAP was similar in all three groups. MAP increased by 29.1±4.4 % from 97.8±5.3 to 
126.2±7.8 mmHg in UX+Ligation group in 2 weeks after surgery and further increase to 
137.64±13.97 mmHg in 12 weeks after surgery (p<0.01 vs. baseline). In contrast, MAP 
in UX+Resection group was only increased by 14.2±2.6 % from 93.5±3.5 to 106.7±6.5 
mmHg in 2 weeks after surgery, and then stabilized. MAP in UX group was constant 
during the experiment (Figure 36). 
A) AT 12 weeks after surgery, plasma creatinine was significant higher in UX+Ligation 
group compared with UX and UX+Resectin groups (n=8; p<0.01 vs. UX and 
UX+Resection groups). B) GFR was significant lower in UX+Ligation group compared 
with UX and UX+Resectin groups (n=8; p<0.05 vs. UX and UX+Resection groups). 
Figure 35. Plasma creatinine and GFR after surgery. 
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We measured mRNA and protein levels of TNFα and IL-6 at 12 weeks after 
surgery. In UX+Ligation group, TNFα mRNA level increased 3.8±0.24 folds (p<0.01 vs. 
UX) compared with UX group (Figure 37A) and IL-6 mRNA level also increased 
4.1±0.81 folds (p<0.01 vs. UX) compared with UX group (Figure 37B). In UX+Resection 
group, TNFα and IL-6 mRNA levels had no significant increase compared with UX 
group.  
MAP after surgery were measured and compared among UX, UX+Ligation and 
UX+Resection groups. At 12 weeks after surgery, MAP increased by 40.6±6.2 % in 
UX+Ligation group, but had no significant increase in UX and UX+Resection groups. 
(n=5; p<0.01 vs. UX and UX+Resection groups). 
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Figure 36. MAP after surgery. 
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The mRNA levels of TNFα and IL-6 were measured and compared among UX, 
UX+Ligation and UX+Resection groups 12 weeks after surgery. A) TNFα mRNA level 
increased 3.8±0.24 folds compared with UX group. (n=6) *p<0.01 vs UX and 
UX+Resection.  B) IL-6 mRNA level increased 4.1±0.81 folds compared with UX group. 
(n=6) *p<0.05 vs UX and UX+Resection. 
 
Figure 38A showed the representative histology images from different groups of 
mice. The UX+Ligation group exhibited the more severe glomerular injury (p<0.05 vs. UX 
group) compared with UX group (Figure 38C). Widened foot process width and GBM 
thickness were observed in UX+Ligation group (p<0.05 vs. UX group) compared with UX 
group (Figure 38B, 38D and 38E).  
Figure 37. Inflammatory factors mRNA level. 
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A) The representative histology images from different groups of mice. B) Transmission 
electron microscopic images from different groups of mice. C) The UX+Ligation group 
exhibited the more severe glomerular injury compared with UX group (n=6) *p<0.05 vs 
UX and UX+Resection. D and E) Widened foot process width and GBM thickness were 
observed in UX+Ligation group compared with UX group (n=5) *p<0.05 vs UX and 
UX+Resection.  
Figure 38. Light microscopy and transmission electron microscopy 
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Discussion 
In the present study, we compared the blood pressure and renal injury in two 5/6 
renal mass reduction models of C57BL/6 mouse achieved via different approaches. We 
found that 5/6 renal mass reduction by uninephrectomy plus 2/3 renal infarction rather 
than 2/3 renal ablation on the contralateral kidney increased blood pressure and 
promoted the development of CKD in C57BL/6 mouse. The divergence in blood 
pressure and CKD progression between these two models might be mediated by the 
stimulated renal and systemic inflammatory response due to the remnant infarcted 
tissue. 
Five-sixths nephrectomy, produced by uninephrectomy and surgical removal of 
2/3 contralateral kidney, is a well-established and widely used CKD model in various 
kinds of laboratory animals, such as dog (Bourgoignie et al. 1987, COBURN et al. 1965, 
Robertson et al. 1986), rabbit (Eddy et al. 1986, Kilicarslan et al. 2003) and rat (Griffin et 
al. 1994, Laouari et al. 1997, Shimamura & Morrison 1975) with the progressive 
reduction in kidney function and the development of renal injury, which mimics the 
feature of CKD in human. However, it has been recognized that the susceptibility to 
develop CKD following 5/6 nephrectomy is strain or genetic background dependent in 
mouse. A recent study by Leelahavanichkul et al. showed that progressive CKD, as 
indicated by the gradual decrease in GFR, the reciprocal changes in blood urea 
nitrogen and serum creatinine, severe albuminuria and mesangial expansion in 
glomeruli, was developed by 4 weeks in CD-1 mice and by 12 weeks in 129S3 mice 
after 5/6 nephrectomy in which the upper and lower poles of the left kidney were 
resected and the whole right kidney was removed. In addition, conscious blood 
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pressure measured by radiotelemetry was significantly elevated in both CD-1 mice and 
129S3 mice following 5/6 nephrectomy. In contrast, C57BL/6 mouse model with 5/6 
nephrectomy exhibited normal blood pressure and was resistant to progressive CKD. 
Besides 5/6 nephrectomy, several other approaches have also been reported to 
achieve a total 5/6 renal mass reduction in rats (Fleck et al. 2006, van et al. 2013, Yang 
et al. 2010).  
Moreover, Along with the common procedure uninephrectomy, approximate 2/3 
renal mass reduction on contralateral kidney by ligating two of the three renal artery 
branches induced higher blood pressure and more severe renal injury, compared with 
the approach by surgical excision of kidney poles. On the basis of these studies in 
Sprague Dawley (SD) rats, in the present study, we sought to determine whether 
subtotal renal mass reduction by renal artery branch ligation rather than ablative surgery 
in C57BL/6 mouse is able to result in similar outcomes in SD rats. Our results 
demonstrated that renal mass reduction by uninephrectomy combined with upper 
branch of renal artery ligation on contralateral kidney induced permanent hypertension 
and the development of CKD in C57BL/6 mice. In contrast, the mouse model with 
surgical excision of the infarction region exhibited normal blood pressure and resistance 
to injury in the remnant kidney, as previous reported 5/6 nephrectomy model with 
resection of kidney poles in C57BL/6 mouse (Leelahavanichkul et al. 2010).  
The mechanism underlying the divergence in blood pressure response and the 
susceptibility to CKD between these two remnant kidney models with different 
approaches remains to be determined.  
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Inflammation has been recognized to promote the development of hypertension 
(Harrison et al. 2011). The elevated C-reactive protein (CRP) level (Bourgault et al. 
2013, Guasti et al. 2011) and the increase in white blood cells count (Antopolsky et al. 
2012b, Bourgault et al. 2013, Lessman et al. 1978) in blood test indicated an 
upregulated systemic inflammatory status in renal infarction patients. Moreover, the 
administration of cyclophosphamide, an immune-suppressor, prevented the blood 
pressure response to partial renal infarct in SD rats, which further suggests the critical 
role of inflammation contributing to the hypertension in renal infarction (Norman, Jr. et 
al. 1988). In the present study, we examined the level of pro-inflammatory cytokines, 
TNF-α and IL-6, in the remnant kidneys from these two different models with reduced 
renal mass. We found that the remnant kidney with upper branch of renal artery ligation 
exhibited upgraded inflammation; in contrast, the remnant kidney with surgical excision 
of the infarction region had normal level of pro-inflammatory cytokines. These results 
are consist with the blood pressure changes in these two mouse models with different 
approaches, indicating the immunological reaction against the infarcted tissue in the 
remnant kidney might be associated with the permanent hypertension in response to 
renal mass reduction by uninephrectomy plus a ligation in upper branch of renal artery 
on contralateral kidney. 
Furthermore, Ang II administration could induce hypertension in C57BL/6 mice 
with 5/6 nephrectomy and overcome the resistance to CKD. The antagonist of Ang II 
type I receptor could decrease the blood pressure and blunt the progression of 5/6 
nephrectomy induced CKD in CD-1 mice. It has also been indicated that the 
upregulation in renin angiotensin aldosterone system (RAAS) is involved with the acute 
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increased blood pressure in renal infarction patients (Arakawa et al. 1970, Candel-Pau 
et al. 2008, Paris et al. 2006). However, our results demonstrated that the plasma renin 
in 5/6 renal mass reduction mouse model with ligation in upper branch of renal artery 
kept stable at normal range, which indicates that the hypertension in this model was 
independent with RAAS. This finding is consistent with the previous studies on renal 
infarction in rats. Norman et al.’s study demonstrated that despite of a transient increase 
in plasma renin activity measured at 1 week after a ligation in two out of three renal 
artery branches in SD rats, the plasma renin activity declined to normal level by 4 weeks 
after renal infarction while hypertension was maintained (Norman, Jr. et al. 1988). 
Munich-Wista rats with 5/6 renal mass reduction exhibited even lower plasma renin 
concentration than sham-operated rats at 4 weeks after renal infarction (Anderson et al. 
1986). Besides the plasma renin, Pupilli et al.’s study also demonstrated that even 
though the intrarenal renin concentration in the infarcted tissue was higher than the 
remnant kidney parenchyma, it was comparable with that in the kidney from sham-
operated rats (Pupilli et al. 1992). Moreover, the fluorescence images of intrarenal 
vascular architecture showed that the blood supply for each specific glomerulus was 
solely originated from only one of the two renal artery branches without any overlapping. 
Thus, ligation of the upper branch of renal artery would not induce partial ischemia in 
JGAs in remnant kidney, which is consistent with the normal plasma renin level in this 
model. Thus, it has been suggested that blood pressure played a critical role in the 
development of CKD in mouse model with 5/6 nephrectomy; the susceptibility to CKD in 
different strains correlated with their blood pressure changes after renal mass reduction 
(Leelahavanichkul et al. 2010).  
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Hypertension has been defined as one of the leading causes of CKD and to 
accelerate the progression of CKD (Chanda & Fenves 2009, Metcalfe 2007, Ritz et al. 
1993). High systemic blood pressure transmitted into glomerular capillary increases the 
mechanical forces in glomerulus. This mechanical insult in glomerulus upregulates the 
cytokines, such as fibronectin (Gruden et al. 2000), transforming growth factor-beta1 
(Gruden et al. 2000), enhances the accumulation of mesangial extracellular matrix 
(Riser et al. 1992), stimulates glomerular monocyte infiltration via an NF-kB and 
monocyte chemoattractant protein-1 mediated pathway (Gruden et al. 2005, Ha et al. 
2002), which promotes the pathogenesis of the glomerular injury.  In the present study, 
significant glomerular injury, as indicated by the progressive proteinuria and 
glomerulosclerosis was observed in the remnant kidney with upper branch of renal 
artery ligation but not in the kidney with surgical excision of the infarction region, which 
was consistent with the divergence of blood pressure in these two reduced renal mass 
models with different approaches, suggesting the critical role of blood pressure in the 
development of CKD in the C57BL/6 mouse model with renal mass reduction.  
Upregulated systemic Inflammation has been recognized to involve in the 
progression of CKD (Gupta et al. 2012, Silverstein 2009). A recent prospective cohort 
study of CKD patients demonstrated that plasma levels of pro-inflammatory biomarkers 
including IL-6 and TNF-alpha were strongly inversely correlated with kidney function, as 
assessed by eGFR and serum cystatin C, and positively associated with glomerular 
injury, as evaluated with albuminuria or urine albumin to creatinine ratio (Gupta et al. 
2012). It has been known that inflammation stimulates oxidative stress (Cachofeiro et al. 
2008, Reuter et al. 2010, Shah et al. 2007), vasoconstriction (Linden et al. 2008, 
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Remuzzi et al. 2005, Vianna et al. 2011), leukocyte adhesion (Betjes 2013, Hill et al. 
1994, Kato et al. 2008), mesangial cell proliferation (Lopez-Novoa et al. 2011, Migliorini 
et al. 2013, Schlondorff & Banas 2009), and tubulointerstitial fibrosis (Hodgkins & 
Schnaper 2012, Ke et al. 2016), which promotes the progression of CKD. Moreover, it 
has been reported that downregulation of inflammation slowed the progression of CKD. 
Quiroz et al.’s study demonstrated that administration of melatonin, a potent anti-
inflammatory hormone produced in pineal gland, significantly attenuated the decline in 
kidney function as indicated by plasma creatinine level and ameliorated the 
deterioration of renal injury, as assessed with proteinuria and glomerulosclerosis, in SD 
rats with 5/6 renal mass reduction (Quiroz et al. 2008). In addition, Clopidogrel, an 
inhibitor of adenosine diphosphate receptor on platelet cell membrance, was reported to 
attenuate the early progression of CKD in Wistar rats by downregulating the systemic 
inflammation (Tu et al. 2008).  Therefore, in the present study, besides blood pressure, 
the inflammatory status in the remnant kidney might also contribute to the divergence in 
CKD in these two C57BL/6 mouse models with different approaches.  
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Chapter Four: Discussion 
 
 
The role of intratubular pressure in acute kidney injury 
In the present study, we found a positive association between the Pt during the 
ischemic phase and the severity of AKI in three widely-used models by clamping of the 
renal arteries, pedicles or veins. To determine the role of Pt during the ischemic phase of 
the development of AKI, we adjusted Pt by altering the renal artery pressure while 
clamping the renal veins. We found that increasing the Pt during the ischemic phase 
exacerbates AKI while lowering the Pt protects against kidney injury.    
Tubular biomechanical forces are involved in the regulation of renal tubular 
function and associated with epithelial cell damage. In obstructive uropathy, increased 
intratubular pressure and tubular stretch upregulate TGFβ-1, contributing to 
tubulointerstitial inflammation and fibrosis (Sato et al. 2003). Also, cyclical stretch on renal 
epithelial cells induces apoptosis by activating JNK/SAPK and p38 SAPK-2 pathways 
(Nguyen et al. 2006). However, little is known about the role of tubular biomechanical 
forces in the development of AKI. Renal vein or pedicle clamping induced more severe 
AKI than renal artery clamping, but the mechanisms are elusive (Liano & Pascual 1996, 
Orvieto et al. 2007). We examined whether tubular pressure during the ischemic phase 
plays any significant role in the development of kidney injury. AKI was induced with 18 
min occlusion of the renal blood flow at 37 ° C in C57BL/6 mice. First, we measured the 
Pt during the ischemic phase in three AKI models. We found that clamping of the renal 
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arteries significantly lowered the Pt below the pre-ischemia basal level. Occlusion of the 
renal arteries created cessation of glomerular filtration, resulting in a decrease of the Pt. 
On the contrary, the Pt was significantly elevated to approximate 50 mmHg by clamping 
the renal veins. The renal venous occlusion lead to kidney congestion, which increased 
the glomerular hydrostatic pressure, consequently resulting in an increase of the Pt. 
Surprisingly, clamping of the renal pedicles also significantly increased the Pt to 
approximately 35 mmHg. We confirmed this finding by tightly ligating the renal pedicles 
with a 6-0 suture to exclude the possibility of incomplete occlusion of the renal blood flow. 
Suture ligation of the renal pedicles raised the Pt to a similar level as clamping of the renal 
pedicles. Thus, this phenotype was not due to the incomplete occlusion of the renal artery. 
However, we do not know the exact mechanism for this phenomenon, which might result 
from decreased tubular reabsorption, tubular obstruction and continued glomerular 
filtration induced by residual pressure after clamping of the pedicles. To our knowledge, 
the present study is the first to examine the Pt during the ischemic phase. Several 
previous studies measured the Pt after reperfusion. Arendshorst et al. examined the Pt 
after occlusion of the renal artery in rats for 60 min in an elegant study (Arendshorst et al. 
1975). They found that at 1-3 hours after reperfusion, the proximal tubules were filled with 
fluid and dilated; the Pt elevated to about 30 mmHg with great heterogeneity (Arendshorst 
et al. 1975). The Pt measured in the other studies were also found to be higher than 
baseline 1-3 days after IRI- or uranyl nitrate-induced AKI (Conger et al. 1984, Eisenbach 
& Steinhausen 1973, Flamenbaum et al. 1974, Tanner & Sophasan 1976). The 
heterogeneity in the Pt observed in these studies may be due to tubular obstructions 
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(Conger et al. 1984, Eisenbach & Steinhausen 1973, Flamenbaum et al. 1974, Tanner & 
Sophasan 1976).  
Although we used the method of Isotope Dilution LC-MSMS to measure creatinine 
in mouse plasma to reduce the background and increase specificity (Takahashi et al. 
2007), we realized the limitation of creatinine as an injury maker in mice, since 50% of 
the creatinine is eliminated via secretion in the mouse kidney tubules (Eisner et al. 2010, 
Vallon et al. 2012). Therefore, we evaluated kidney injury combined with changes in KIM-
1, NGAL, and histology in these three AKI models. We found that at 24 hours after renal 
ischemia, clamping of the renal veins induced the most severe AKI while clamping of the 
renal arteries induced the least renal injury. These results were consistent with the results 
from previous studies (Liano & Pascual 1996, Orvieto et al. 2007). Therefore, the Pt during 
the ischemic phase in these three models was positively associated with the severity of 
AKI. 
Acute reduction in renal blood flow in various clinical situations, such as in 
hypovolemic shock, some cardiac and abdominal surgeries, cardiac arrest, acute left 
heart failure, and kidney transplantation, etc. is often caused by renal arterial hypo-
perfusion. In such case, the renal artery clamping model should better mimic these clinical 
conditions. Clamping of the renal vein is more consistent with clinical situations of vein 
thrombosis, chronic right heart failure, or severe liver cirrhosis. Even though occlusion of 
both the renal artery and vein is not a typical clinical scenario, clamping of the renal 
pedicle is the most common choice for the rodent AKI models, probably due to the 
technical challenge of isolating murine renal arteries. In consideration of the significant 
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difference in renal injury in different models, comparison and interpretation of these 
results should be conducted cautiously. 
To determine the significance of Pt during the ischemic phase of the development 
of AKI, we modulated the Pt by adjusting the renal artery pressure while clamping the 
renal veins. To adjust the renal artery pressure, we constricted the aorta and mesenteric 
artery, rather than clamp them to avoid ischemic injury of tissues supplied by the  aorta 
and mesenteric artery. Constriction of the aorta above the renal arteries lowered the renal 
artery pressure, which led to a decrease in the Pt compared with the normal renal artery 
pressure group. On the contrary, constriction of the aorta and the superior mesenteric 
artery raised the renal artery pressure, which resulted in an increase in the Pt. The kidney 
injury markers were compared at 24 hours after renal ischemia. Mice with a lower Pt in 
the ischemic phase exhibited less renal injury than mice with a normal Pt, while mice with 
an elevated Pt showed more severe renal injury. Therefore, these results suggested that 
Pt during the ischemic phase contributes to the development of AKI. A lower Pt in the 
ischemic phase protects against the development of AKI, while a higher Pt aggravates 
the progression of AKI. Under physiological conditions, renal autoregulation maintains the 
renal blood flow and GFR relatively constant, despite fluctuations in the arterial blood 
pressure over a range  of about 80-160 mmHg.  This buffers the transmission of 
alterations in the arterial blood pressure into the renal tubules (Carlstrom et al. 2015, 
Loutzenhiser et al. 2006). However, ischemia may impair this auto-regulatory capacity, 
resulting in the loss of independent stability in tubular dynamics, thereby permitting the 
arterial pressure transmitted to the intra-glomerulus and tubules (Adams et al. 1980, Guan 
et al. 2006). 
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The role of renal temperature in acute kidney injury 
In the present study, we develop and characterize a novel in vivo IRI-induced AKI 
model that is exclusively induced by cold ischemia, which provides a new tool to 
investigate renal IRI in kidney transplantation. 
In this model, the blood in the kidney was first flushed out with cold saline and 
then the kidney was maintained in a kidney cup with circulating cold saline. IRI was 
induced by clamping of the renal pedicle. The body temperature was maintained at 
37°C during the experiment. After releasing the clip on the renal pedicle, the kidney cup 
was removed and the kidney was reperfused by blood at body temperature. This 
approach mimics the cold ischemia and kidney transplantation surgical procedures but 
avoids warm ischemia.  
Although UW solution is the primary choice for cold storage of deceased donor 
kidneys in clinical transplantation (Belzer et al. 1992, Muhlbacher et al. 1999, Southard 
et al. 1990), various kinds of perfusion and preservation solutions, including normal 
saline (Martins 2006, Rong et al. 2012, Tian et al. 2010), phosphate buffered saline 
(Lutz et al. 2007), Ringer’s solution (Wang et al. 2003b) and UW solution (Tse et al. 
2014) are used in mouse kidney transplantation. While the effects of different solutions 
in mouse kidney transplants have not been compared, it has been considered that the 
preservation solutions with sticky properties may result in obstructions of the 
microcirculation in mice (Tse et al. 2014). Hence, we perfused and preserved the kidney 
with cold saline during the ischemic stage in this model, as most recent studies did in 
mouse kidney transplants (Rong et al. 2012, Tian et al. 2010, Tse et al. 2013).  
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The severity of renal injury induced by ischemia is associated with the ischemic 
times (Bonventre & Yang 2011, Munshi et al. 2011, Wei & Dong 2012). As indicated by 
the levels of plasma creatinine, KIM-1, NGAL, and histology, the mice with 5 hours of 
cold renal ischemia induced severe AKI and died with 2-3 days after cold IRI. The mice 
with less than 2 hours of cold ischemia had no significant kidney injury. Thus, in this 
model, the severity of renal injury could be easily controlled by adjusting the duration of 
cold ischemia in the kidney. The plasma creatinine level and GFR at 7 days after 
surgery indicated that the mice made almost a full recovery of renal function from 
moderate AKI induced by less than 3 hours cold ischemia. This is consistent with the 
clinical situation in deceased-donor kidney transplant in which the prolonged cold 
ischemia time is associated with a higher risk of delayed graft function and a lower graft 
survival rate (Kayler et al. 2011, Perez Valdivia et al. 2011, Sert et al. 2014). It has been 
well-documented that the corticomedullary region, comprising the S3 segment of the 
proximal tubule and thick ascending limb, is most susceptible in IRI (Bonventre & Yang 
2011, Devarajan 2006). The histology of this cold renal IRI model showed the same 
pattern that the most severe tubular injury was observed in the CMR with the largest 
percentage of necrotic tubules. However, in this model, the inner medulla exhibited 
diffuse tubular obstruction by casts, which is inconsistent with warm renal IRI models, 
suggesting that the pathophysiological changes and mechanisms of IRI induced by cold 
ischemia might be distinguished from those caused by warm ischemia (Bonventre & 
Yang 2011, Devarajan 2006).    
This innovative in vivo renal ischemia model offers the potential to investigate the 
distinctive pathophysiological changes in cold ischemia reperfusion induced AKI beyond 
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the traditional AKI models induced by warm renal ischemia reperfusion. In addition, by 
using this new model, it becomes possible to investigate the differences and similarities 
in signal pathway and mechanisms of AKI induced by warm or cold ischemia. The 
availability of this model in the mouse further advances the capacity for investigation of 
mechanisms with the utilization of genetically modified mice. Moreover, by changing the 
perfusion and preservation solutions, the effect upon the cold storage of any potential 
therapeutic agent or novel organ preservation solution in kidney transplant can be 
assessed in this model. 
 
The role of tubuloglomerular feedback in acute kidney injury 
In the present study, we examined 1) the effect of renal pH on TGF response and 
the activity and expression of NOS1β in the macula densa; 2) the TGF responsiveness 
change and the alteration of NOS1β activity and expression in the macula densa in IRI-
induced AKI; and 3) the effect of bicarbonate treatment on the development of IRI-
induced AKI. We found that 1) renal pH modulates TGF response by regulating NOS1β 
in the macula densa; 2) renal IRI downregulates NOS1β in the macula densa and 
enhances TGF response, which promotes the development of AKI; and 3) bicarbonate 
treatment protected against IRI-induced AKI by upregulating NOS1β in the macula 
densa. 
In both humans and experimental animals, reductions in GFR have been 
attributed to persistent vasoconstriction. An intense and persistent renal 
vasoconstriction that reduces overall kidney blood flow and GFR has long been 
considered a hallmark of AKI (Lameire et al. 2005, Mason et al. 1977). In fact, ischemic 
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AKI has been referred to as “vasomotor nephropathy”. A severe injury of the proximal 
tubular in renal cortex and TAL in the outer medulla is a uniform feature in various forms 
of AKI while the glomeruli are morphologically normal (Heyman et al. 1988, Lieberthal & 
Nigam 1998, Oken 1975, Regner et al. 2009). Tubular injury can also lead to a 
decrease in GFR by tubular obstruction with epithelial debris and backleak. However, 
normal pressures have been observed in several tubules, making it unlikely for tubular 
obstruction to be the singularly important mediator of reduction in GFR after ischemic 
injury (Conger et al. 1984). Arendshorst et al.(Arendshorst et al. 1975) studied severe 
AKI after 1 h of unilateral renal ischemia. They found that in the early stages (1-3 h) 
after ischemia, the pressures in the proximal and distal tubules were elevated, and there 
was histological evidence of tubular obstruction. Tubular obstruction appeared to be the 
predominant factor in the decline in filtration rate at this stage. However, at a later time-
point (22-26 h), tubular pressures were normal, but preglomerular vasoconstriction was 
marked and this was thought to contribute to the persistent decline in filtration rate. In 
addition, tubular obstruction does not appear to be a significant pathogenic mechanism 
in AKI in humans, in which only about 10% decrease in GFR could be explained by 
tubular backleak (Blantz & Singh 2011, Braam et al. 1993, Myers et al. 1979, Schrier et 
al. 2004). A single nephron model of nephrotoxic tubular injury was established by 
microperfusion of uranyl nitrate into the early proximal tubule (Peterson et al. 1989). 
Within minutes of intratubular administration of uranyl nitrate, a 16-30% reduction in 
SNGFR was observed. The local mechanism such as TGF could be invoked to explain 
the immediate decline in SNGFR. Similar findings have been observed in the uranyl 
nitrate model of AKI by another group (Flamenbaum et al. 1974). Hence, an increase in 
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preglomerular resistance appears to be consistent in nearly all forms of AKI and TGF 
has been postulated to dictate the enhanced preglomerular vascular resistance and 
reduction in GFR in AKI (Thurau & Boylan 1976). In present study, we measured TGF in 
vivo with micropuncture right after and 7days after following 18 min clamping of renal 
arteries. The results indicate that renal ischemia impairs TGF response early after IRI, 
but enhances TGF response later after IRI.  
As an enzyme to catalyze the generation of NO and citrulline from L-arginine, 
NOS1 is affected by pH. However, the optimal pH for NOS1 is controversial in previous 
studies. The maximal efficiency of NOS1 was measured at a pH 6.7 with the brain 
tissue (Chen et al. 1997). However, the most favorable pH for NOS1 in the kidney tissue 
was indicated to be around 8.0 (Liu et al. 2004a, Wang et al. 2003a). There are three 
splice variants of NOS1, α, β, and γ. NOS1α is the primary isoform in brain but NOS1β 
is the majority in kidney. Hence, in present study, we generated the distinct NOS1α and 
NOS1β by their expression vectors and measured the activity under conditions with 
graded pH environment. The results indicated that the most favable pH for NOS1α was 
6.5 and the optimium for NOS1β was 7.9, which is consistant of the previous studies 
and explains the controversy. 
In previous studies, we reported that the NO generation by the macula densa 
enhances during TGF response (Liu et al. 2004a). The activation of nNOS is mediated 
by elevation of intracellular pH in the macula densa via NHE (Liu et al. 2004a). 
Microperfusion studies showed when luminal pH was increased, there was a linear 
correlation between changes in intracellular pH and extracellular pH in macula densa, 
and intracellular pH of the macula densa at high NaCl was always higher than at low 
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NaCl (Liu et al. 2008). Also, in cultured tubular cells decreasing pH in culture medium 
with different concentration of NaHCO3 accordingly reduced intracellular pH (Yaqoob et 
al. 1996). These studies indicate changing luminal pH can be used to alter intracellular 
pH. In our study, it is very likely that modulation of luminal pH took effect by altering 
intracellular pH. During TGF response NO concentration by the macula densa 
increased significantly (Liu et al. 2002). The inhibition of NO generation by either NOS 
blockers (Welch & Wilcox 1997) or specific nNOS inhibitors (Ren et al. 2000b, Welch et 
al. 2000) enhances TGF responsiveness both in vivo and in vitro. We previously found 
that raising intracellular pH of the macula densa from 7.3 to 7.8 significantly increased 
NO concentration in microdissected and perfused macula densa and 7-Nitroindazole 
blocked the increase of NO induced by elevated pH (Liu et al. 2004a). In present study, 
we found tubular pH directly regulate TGF responsiveness at the macula densa in vivo 
with micropuncture and in vitro with microperfusion. Increases of pH in tubules blunt 
TGF response. NOS inhibition eliminated this effect, indicating NO mediated the 
attenuation of TGF induced by elevation of tubular pH.       
Current guidelines for CKD patients recommend alkali treatment with sodium 
citrate or sodium bicarbonate for those with serum total CO2 less than 22 mM (2000). 
Indeed, the correlation between low serum bicarbonate level and progressive decline in 
eGFR has been studied extensively in patients with CKD. Alkali therapy reduces kidney 
injury and slows nephropathy progression in patients with CKD (de Brito-Ashurst et al. 
2009, Dobre et al. 2015, Eustace et al. 2004, Goraya et al. 2012, Kovesdy et al. 2009, 
Mahajan et al. 2010, Navaneethan et al. 2011, Phisitkul et al. 2010, Raphael et al. 2011, 
Shah et al. 2009, Susantitaphong et al. 2012), but the mechanism is not clear. Diet can 
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markedly affect acid-base status and it significantly influences CKD and its 
progression. In the National Health and Nutrition Examination Survey, 11,957 adults 
were analyzed  and found that high serum anion gap values and decreased serum total 
CO2 concentration were associated with increased mortality in the general population 
and with a decline in eGFR in patients with CKD (Abramowitz et al. 2012). In a separate 
study, the correlation between dietary acid load and eGFR were assessed in 12,293 US 
adults. High dietary acid load was found to be associated with albuminuria and low 
eGFR (Banerjee et al. 2014). A cross-sectional study of the African American Study of 
Kidney Disease and Hypertension cohort indicate that a higher acid load and lower total 
serum CO2 concentration (reflects serum bicarbonate concentration) correlate with more 
severe CKD and readily decline of eGFR (Scialla et al. 2011). Oral bicarbonate 
supplementation slows CKD progression in humans (de Brito-Ashurst et al. 
2009). Recent two intervention studies, one in patients with early CKD without metabolic 
acidosis (Goraya et al. 2012), and the other in patients with advanced CKD and 
metabolic acidosis (Goraya et al. 2013), suggest that a diet rich in fruits and vegetables 
can improve renal function and slow the progression of CKD. In patients at risk of CKD, 
alkali-generating diets that are rich in fruits and vegetables reduce the risk of developing 
CKD (Chang et al. 2013, Dunkler et al. 2013, Lin et al. 2011, Nettleton et al. 2008, 
Scialla et al. 2011). Oral bicarbonate supplementation has been found to delay the 
decline of GFR in CKD patients (Dobre et al. 2015, Eustace et al. 2004, Kovesdy et al. 
2009, Navaneethan et al. 2011, Raphael et al. 2011, Shah et al. 2009, Susantitaphong 
et al. 2012), but the mechanism is not clear. Recently, the relationship between serum 
bicarbonate and GFR has been analyzed in people with normal renal functions. Lower 
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serum bicarbonate concentrations are found to be associated independently with rapid 
decline of eGFR in a study of 5422 adults; in a Multi-Ethnic Study of Atherosclerosis of 
5810 participants (Driver et al. 2014), and in a Health, Aging, and Body Composition 
study (Goldenstein et al. 2014). The baseline eGFR of most or all of the participants in 
these studies is above 60 mL/min/1.73 m2. Dietary acid load has also been found an 
important determinant of kidney injury in rat models of CKD with and without metabolic 
acidosis (Khanna et al. 2004, Mahajan et al. 2010, Nath et al. 1985, Phisitkul et al. 
2010, Wesson et al. 2006, Wesson & Simoni 2010). In present study, we measured 
GFR and plasma creatinine 7 days after IRI in bicarbonate treated C57BL/6J and MD-
NOS1KO mice. We found NaHCO3 treatment can limit the decrease of GFR and the 
increase of plasma creatinine in C57BL/6J mice, but this limitation was attenuated in 
MD-NOS1KO mice. The results indicate upregulation of NOS1β in the macula densa by 
a high bicarbonate intake could be a novel mechanism, but also a potential target for 
prevention and treatment for IRI-induced AKI. 
 
Renal infarction and hypertension 
In the present study, we developed a partial renal infarction model in C57BL/6 
mouse by ligating one of the two renal artery branches in the left kidney with an intact 
contralateral kidney.  MAP significantly raised in mice with either branch ligation. PRC 
and HR were increased. Inflammatory response was enhanced. Resection of the 
infarction zone normalized blood pressure. 
In human, the renal artery is typically divided into five segmental arteries near the 
renal hilum with one posterior and four anterior (el-Galley & Keane 2000, Urban et al. 
132 
 
2001). Accessory renal artery is a common vascular variant in human and exists in 
approximately one-third of the population (Spring et al. 1979, Urban et al. 2001). 
Moreover, the anatomy of renal artery and even its branching have been well 
characterized in various kinds of laboratory animals, like dog (Marques-Sampaio et al. 
2007), pig (Evan et al. 1996, Sampaio et al. 1998), rabbit and rat (Fuller & Huelke 1973, 
Yoldas & Dayan 2014). However, the morphology of the renal artery in mouse, in 
particularly, the most used laboratory rodent C57BL/6 mouse was not documented 
before. On the basis of our observation in current study, accessory renal artery is rare in 
C57BL/6 mouse; the left renal artery is bifurcate into two branches at approximate 5 to 
10 mm before entering parenchyma; the diameter of upper branch is generally about 
twice of the lower, suggesting the renal blood supply via the upper branch is larger than 
that through the lower. Accordingly, ligation of upper branch causes ischemia of nearly 
2/3 kidney in the upper portion, while occlusion of the lower branch results in 
approximate 1/3 renal parenchymal ischemia in the lower part of the kidney. Moreover, 
as the branching site of either adrenal artery or ureteral artery from the stem of renal 
artery is prior to the bifurcation point of the renal artery branches, ligation in either 
branch of renal artery would not effect on the blood supply to the adrenal grand or 
ureter. 
To characterize the vascular architecture originated from the two renal artery 
branches, tomato lectin with different conjugated fluorophores was perfused via either 
upper or lower branch respectively to distinguish the vasculature from each other. 
Tomato lectin, a kind of subunit glycoprotein from Lycopersicon esculentum is utilized in 
the visualization of vasculature on account of its capacity of binding to glycocalyx of 
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vascular endothelium. The fluorescence images of the whole kidney slice showed a 
clear border between green and red signals which indicated that the vasculature 
distributed in the upper portion of renal parenchyma had its origin from the upper renal 
artery branch; on the contrary, the rest renal vasculature existed in the lower part of the 
kidney was originated solely from the other renal artery branch. In the border zone, 
even though some peritubular capillaries exhibited both green and red color, for each 
specific glomerulus, either red or green fluorescence signal displayed only, indicating no 
overlapping in blood supply for glomeruli between the two branches.   
To determine the changes in blood pressure after partial renal infarction, we 
measured the MAP with the telemetry system. Blood pressure raised rapidly and 
peaked at 2 to 3 days after surgery, then gradually declined but kept at an elevated 
level throughout the remainder experiment course. Even though the upper renal artery 
branch supplies more blood flow to a larger portion of the renal parenchyma compared 
with the lower branch, there is no significant difference in MAP between the renal 
infarction models with the ligation in either upper or lower branch. While no studies in 
mouse models, Griffin et al. reported that renal mass reduction in Sprague-Dawley rats 
by unilateral ligation in one or two of the three renal artery branches plus 
uninephrectomy of contralateral kidney resulted in a significant increase in systolic 
blood pressure with the peak at 3 to 5 days after surgery (Griffin et al. 1994). In addition, 
previous studies by Fekete et al. (Fekete et al. 1975) and Tarjan et al. (Tarjan & Fekete 
1975)  demonstrated that unilateral total kidney ligation in rats induced hypertension. 
Inflammation has been demonstrated to play an essential role in the 
development of hypertension (Das 2006, Guzik et al. 2007, Majid et al. 2015). Patients 
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with renal infarction exhibit enhanced inflammatory response (Antopolsky et al. 2012a, 
Bourgault et al. 2013, Korzets et al. 2002). Hence, in regard to the underlying 
mechanisms contributing to the blood pressure outcomes after renal infarction in the 
present study, we examined the level of pro-inflammatory cytokines, TNF-α and IL-6, in 
both partially infarcted kidney and plasma. We found that renal infarction not only 
resulted in local inflammation but also lead to upgraded systemic inflammatory status. 
Furthermore, resection of the infarction zone normalized the blood pressure and 
significantly reduced the pro-inflammatory cytokines level. These results consist with the 
clinical outcomes of renal infarction patients that nephrectomy of the infarction zone 
ameliorated hypertension (Paris et al. 2006). In addition, our finding is also consistent 
with the previous studies on renal mass reduction, in which compared with the approach 
with excision of both kidney poles, the reduction of renal parenchyma mass in Sprague-
Dawley rats by ligating two of the three artery branches induced higher blood pressure 
with an enhanced renal inflammation (Griffin et al. 1994).  
Besides inflammation, renal infarction induced hypertension in clinical patients is 
also associated upregulated renin angiotensin system (Arakawa et al. 1970, Candel-
Pau et al. 2008, Paris et al. 2006). Similarly, current study also demonstrated that 
ligation in renal artery branch initially induced upregulation in plasma renin. However, it 
returned to normal within a week and stayed at a normal level, but the blood pressure 
maintained at the similar high level. Renin is generated and released from granular cells 
in JGA and its secretion is controlled by renal baroreceptor, sodium chloride delivery at 
macula densa and sympathetic nervous system (Kurtz 2011, Peti-Peterdi & Harris 2010, 
Vander 1967). The fluorescence images of intrarenal vascular architecture indicated 
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that the blood supply of each specific glomerulus was solely from only one of the two 
renal artery branches without any overlapping. Thus, ligation of either branch of renal 
artery would not induce partial ischemia in JGAs, which could promote renin release like 
in 2K1C model. Therefore, the increased level of plasma renin might be partially 
released from the JGAs in the infarction area before they turn to ischemic necrosis. On 
the other hand, the heart rate, which represents the intensity of sympathetic nerve 
activity (Petretta et al. 1997, Robinson et al. 1966), was significantly increased after 
renal infarction and gradually decline to basaline along with the change in plasma renin. 
These results indicate that the enhanced sympathetic activity may contribute to the 
increased plasma renin concentration.  
 
Renal infarction and chronic kidney disease 
In the present study, we compared the blood pressure and renal injury in two 5/6 
renal mass reduction models of C57BL/6 mouse achieved via different approaches. We 
found that 5/6 renal mass reduction by uninephrectomy plus 2/3 renal infarction rather 
than 2/3 renal ablation on the contralateral kidney increased blood pressure and 
promoted the development of CKD in C57BL/6 mouse. The divergence in blood 
pressure and CKD progression between these two models might be mediated by the 
stimulated renal and systemic inflammatory response due to the remnant infarcted 
tissue. 
Five-sixths nephrectomy, produced by uninephrectomy and surgical removal of 
2/3 contralateral kidney, is a well-established and widely used CKD model in various 
kinds of laboratory animals, such as dog (Bourgoignie et al. 1987, COBURN et al. 1965, 
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Robertson et al. 1986), rabbit (Eddy et al. 1986, Kilicarslan et al. 2003) and rat (Laouari 
et al. 1997, Shimamura & Morrison 1975) with the progressive reduction in kidney 
function and the development of renal injury, which mimics the feature of CKD in 
human. However, it has been recognized that the susceptibility to develop CKD 
following 5/6 nephrectomy is strain or genetic background dependent in mouse. A 
recent study by Leelahavanichkul et al. showed that progressive CKD, as indicated by 
the gradual decrease in GFR, the reciprocal changes in blood urea nitrogen and serum 
creatinine, severe albuminuria and mesangial expansion in glomeruli, was developed by 
4 weeks in CD-1 mice and by 12 weeks in 129S3 mice after 5/6 nephrectomy in which 
the upper and lower poles of the left kidney were resected and the whole right kidney 
was removed. In addition, conscious blood pressure measured by radiotelemetry was 
significantly elevated in both CD-1 mice and 129S3 mice following 5/6 nephrectomy. In 
contrast, C57BL/6 mouse model with 5/6 nephrectomy exhibited normal blood pressure 
and was resistant to progressive CKD. Besides 5/6 nephrectomy, several other 
approaches have also been reported to achieve a total 5/6 renal mass reduction in rats 
(Fleck et al. 2006, van et al. 2013, Yang et al. 2010).  
Moreover, Along with the common procedure uninephrectomy, approximate 2/3 
renal mass reduction on contralateral kidney by ligating two of the three renal artery 
branches induced higher blood pressure and more severe renal injury, compared with 
the approach by surgical excision of kidney poles. On the basis of these studies in 
Sprague Dawley (SD) rats, in the present study, we sought to determine whether 
subtotal renal mass reduction by renal artery branch ligation rather than ablative surgery 
in C57BL/6 mouse is able to result in similar outcomes in SD rats. Our results 
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demonstrated that renal mass reduction by uninephrectomy combined with upper 
branch of renal artery ligation on contralateral kidney induced permanent hypertension 
and the development of CKD in C57BL/6 mice. In contrast, the mouse model with 
surgical excision of the infarction region exhibited normal blood pressure and resistance 
to injury in the remnant kidney, as previous reported 5/6 nephrectomy model with 
resection of kidney poles in C57BL/6 mouse (Leelahavanichkul et al. 2010).  
The mechanism underlying the divergence in blood pressure response and the 
susceptibility to CKD between these two remnant kidney models with different 
approaches remains to be determined.  
Inflammation has been recognized to promote the development of hypertension 
(Harrison et al. 2011). The elevated C-reactive protein (CRP) level (Bourgault et al. 
2013, Guasti et al. 2011) and the increase in white blood cells count (Antopolsky et al. 
2012b, Bourgault et al. 2013, Lessman et al. 1978) in blood test indicated a upregulated 
systemic inflammatory status in renal infarction patients. Moreover, the administration of 
cyclophosphamide, an immune-suppressor, prevented the blood pressure response to 
partial renal infarct in SD rats, which further suggests the critical role of inflammation 
contributing to the hypertension in renal infarction (Norman, Jr. et al. 1988). In the 
present study, we examined the level of pro-inflammatory cytokines, TNF-α and IL-6, in 
the remnant kidneys from these two different models with reduced renal mass. We 
found that the remnant kidney with upper branch of renal artery ligation exhibited 
upgraded inflammation; in contrast, the remnant kidney with surgical excision of the 
infarction region had normal level of pro-inflammatory cytokines. These results are 
consist with the blood pressure changes in these two mouse models with different 
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approaches, indicating the immunological reaction against the infarcted tissue in the 
remnant kidney might be associated with the permanent hypertension in response to 
renal mass reduction by uninephrectomy plus a ligation in upper branch of renal artery 
on contralateral kidney. 
Furthermore, Ang II administration could induce hypertension in C57BL/6 mice 
with 5/6 nephrectomy and overcome the resistance to CKD. The antagonist of Ang II 
type I receptor could decrease the blood pressure and blunt the progression of 5/6 
nephrectomy induced CKD in CD-1 mice. It has also been indicated that the 
upregulation in renin angiotensin aldosterone system (RAAS) is involved with the acute 
increased blood pressure in renal infarction patients (Arakawa et al. 1970, Candel-Pau 
et al. 2008). However, our results demonstrated that the plasma renin in 5/6 renal mass 
reduction mouse model with ligation in upper branch of renal artery kept stable at 
normal range, which indicates that the hypertension in this model was independent with 
RAAS. This finding is consistent with the previous studies on renal infarction in rats. 
Norman et al.’s study demonstrated that despite of a transient increase in plasma renin 
activity measured at 1 week after a ligation in two out of three renal artery branches in 
SD rats, the plasma renin activity declined to normal level by 4 weeks after renal 
infarction while hypertension was maintained (Norman, Jr. et al. 1988). Munich-Wista 
rats with 5/6 renal mass reduction exhibited even lower plasma renin concentration than 
sham-operated rats at 4 weeks after renal infarction (Anderson et al. 1986). Besides the 
plasma renin, Pupilli et al.’s study also demonstrated that even though the intrarenal 
renin concentration in the infarcted tissue was higher than the remnant kidney 
parenchyma, it was comparable with that in the kidney from sham-operated rats (Pupilli 
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et al. 1992). Moreover, the fluorescence images of intrarenal vascular architecture 
showed that the blood supply for each specific glomerulus was solely originated from 
only one of the two renal artery branches without any overlapping. Thus, ligation of the 
upper branch of renal artery would not induce partial ischemia in JGAs in remnant 
kidney, which is consistent with the normal plasma renin level in this model. Thus, it has 
been suggested that blood pressure played a critical role in the development of CKD in 
mouse model with 5/6 nephrectomy; the susceptibility to CKD in different strains 
correlated with their blood pressure changes after renal mass reduction 
(Leelahavanichkul et al. 2010).  
Hypertension has been defined as one of the leading causes of CKD [32, 33, 34] 
and to accelerate the progression of CKD (Chanda & Fenves 2009, Metcalfe 2007, Ritz 
et al. 1993). High systemic blood pressure transmitted into glomerular capillary 
increases the mechanical forces in glomerulus. This mechanical insult in glomerulus 
upregulates the cytokines, such as fibronectin (Gruden et al. 2000), transforming growth 
factor-beta1 (Gruden et al. 2000), enhances the accumulation of mesangial extracellular 
matrix (Riser et al. 1992), stimulates glomerular monocyte infiltration via an NF-kB and 
monocyte chemoattractant protein-1 mediated pathway (Gruden et al. 2005, Ha et al. 
2002), which promotes the pathogenesis of the glomerular injury.  In the present study, 
significant glomerular injury, as indicated by the progressive proteinuria and 
glomerulosclerosis was observed in the remnant kidney with upper branch of renal 
artery ligation but not in the kidney with surgical excision of the infarction region, which 
was consistent with the divergence of blood pressure in these two reduced renal mass 
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models with different approaches, suggesting the critical role of blood pressure in the 
development of CKD in the C57BL/6 mouse model with renal mass reduction.  
Upregulated systemic Inflammation has been recognized to involve in the 
progression of CKD (Gupta et al. 2012, Silverstein 2009). A recent prospective cohort 
study of CKD patients demonstrated that plasma levels of pro-inflammatory biomarkers 
including IL-6 and TNF-alpha were strongly inversely correlated with kidney function, as 
assessed by eGFR and serum cystatin C, and positively associated with glomerular 
injury, as evaluated with albuminuria or urine albumin to creatinine ratio (Gupta et al. 
2012). It has been known that inflammation stimulates oxidative stress (Cachofeiro et al. 
2008, Reuter et al. 2010, Shah et al. 2007), vasoconstriction (Linden et al. 2008, 
Remuzzi et al. 2005, Vianna et al. 2011), leukocyte adhesion (Betjes 2013, Hill et al. 
1994, Kato et al. 2008), mesangial cell proliferation (Lopez-Novoa et al. 2011, Migliorini 
et al. 2013, Schlondorff & Banas 2009), and tubulointerstitial fibrosis (Hodgkins & 
Schnaper 2012, Ke et al. 2016), which promotes the progression of CKD. Moreover, it 
has been reported that downregulation of inflammation slowed the progression of CKD. 
Quiroz et al.’s study demonstrated that administration of melatonin, a potent anti-
inflammatory hormone produced in pineal gland, significantly attenuated the decline in 
kidney function as indicated by plasma creatinine level and ameliorated the 
deterioration of renal injury, as assessed with proteinuria and glomerulosclerosis, in SD 
rats with 5/6 renal mass reduction (Quiroz et al. 2008). In addition, Clopidogrel, an 
inhibitor of adenosine diphosphate receptor on platelet cell membrance, was reported to 
attenuate the early progression of CKD in Wistar rats by downregulating the systemic 
inflammation (Tu et al. 2008).  Therefore, in the present study, besides blood pressure, 
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the inflammatory status in the remnant kidney might also contribute to the divergence in 
CKD in these two C57BL/6 mouse models with different approaches.  
 
Summary 
In the present study, we investigated the pathophysiological mechanisms of renal 
ischemia related kidney diseases. Temporary ischemia could lead to renal ischemia 
reperfusion induced AKI.  We determined the role of various factors including intratubal 
pressure, renal temperature and renal pH in ischemia reperfusion induced AKI and we 
found that 1) Increased intratubular pressure of the proximal tubule during the ischemic 
phase exacerbates renal ischemia reperfusion injury and promotes the development of 
AKI; 2) the pathophysiological changes and the underlying mechanisms in renal IRI 
induced by cold ischemia is different with that induced by warm ischemia; 3) 
bicarbonate treatment elevate renal pH and protected against IRI-induced AKI by 
upregulating NOS1β in the macula densa. Permanent ischemia in kidney could result in 
renal infarction. We examined the effect of permanent renal ischemia on the 
development of CKD in the remnant kidney tissue and we found that permanent 
ischemia induced renal infarction increases blood pressure and promotes CKD 
progression. 
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Appendix: List of Abbreviation 
 
 
AKI   Acute kidney injury 
Af-Art      Afferent arteriole  
CKD                                                                   Chronic kidney disease 
CO2                                                              Carbon dioxide 
CMR                                        Corticomedullary region 
DMEM                                     Dulbecco’s modified eagle’s medium-low glucose 
DAF-2 DA                                4-amino-5-7’-difluorofluorescein diacetate methylamino-2'  
eGFR                                       Estimated glomerular filtration rate 
GFR                                         Glomerular filtration rate 
IRI                                            Ischemia reperfusion injury 
IM                                             Inner medullar 
JGA                                         Juxtaglomerular apparatus 
KIM-1                                       Kidney injury molecule–1 
MAP                                         Mean arterial pressure 
MD-NOS1KO mice                  Macula densa specific NOS1 knockout mice 
NO                                           Nitric oxide 
NGAL                                    Neutrophil gelatinase-associated lipocalin 
OM                                          Outer medulla 
Pt                                             Proximal tubular pressure 
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PAS                                         Periodic Acid Schiff 
Psf                                            Stop-flow pressure 
PRC                                         Plasma renin concentration 
PCR                                        Polymerase chain reaction 
RBF                                        Renal blood flow 
SNGFR                                  Single nephron glomerular filtration rate 
TAL                                        Thick ascending limb 
TGF                                       Tubuloglomerular feedback 
TGFβ-1                                  Transforming growth factor β-1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
